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ABSTRACT 
In pigs, successful in vitro production of embryos (IVP) faces significant challenges due to many 
defects in various steps of this technique, including: in vitro maturation of oocytes, in vitro 
fertilization, and in vitro culture of embryos. Poor cytoplasmic maturation of oocytes is 
considered the main factor for low rate of IVP of pig embryos. One of the main causes of this 
problem is the insufficient time for cytoplasm of oocytes to be matured due to the loss of 
communications between cumulus cells and oocytes. Recently, a new strategy emerged to inhibit 
meiotic resumption and provide more time to accumulate important factors for oocytes 
competence. The overall hypothesis of this thesis was that delaying meiotic resumption during 
the in vitro maturation will have a positive effect on oocytes competence for fertilization and 
embryo development in an in vitro environment.  
In our first study (Chapter 3), the first experiment was designed to evaluate the effect of 
natriuretic peptide precursor type C (NPPC, 100-1000 nM), cyclic guanosine monophosphate 
(cGMP, 2-10 µM), cyclic adenosine 3, 5monophosphate (cAMP, 0.5-2 mM), nitric oxide (NO, 
0.5-2 mM), and steroid hormones (testosterone, 500-1000 ng/ml ; progesterone, and estradiol, 
100 ng/ml for each) to delay resumption of nuclear maturation during in vitro maturation of 
porcine cumulus oocyte complexes (COCs). Meiotic resumption was inhibited at an optimum 
concentration of 1000 nM for NPPC, 1mM for dbcAMP and NO, and 100 ng/ml for estradiol. 
The other substances (cGMP, testosterone, and progesterone) could not inhibit the meiotic 
resumption. Using the inhibitory substances, the second experiment evaluated the effect of 
delaying nuclear maturation for different times during IVM process (2, 6, 18, 22 hrs). Estradiol, 
NPPC, cAMP, or a combination of these substances were able to inhibit the meiotic resumption 
for 22 hrs. Three treatments (NPPC + estradiol (NE); cAMP (CA); NPPC + estradiol + cAMP 
(CANE)) were chosen to delay nuclear maturation (n= 450-500 COCs /group) and evaluate their 
effects on embryo development. Interestingly, blastocyst rate ranged from 6.0-8.7% and did not 
differ between the treatment groups or treatments to the control (9.4%, porcine follicular fluid in 
maturation medium, Pff). The selected treatment could be considered a base to develop a 
medium without animal source products like Pff.  
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As a part of the second experiment (Chapter 4), the effects of inhibitory substances (NE, CA, 
CANE) on molecular pathway and gene expression profile of in vitro matured pig oocytes was 
evaluated. Microarray technology was used to assess the genes expression profile associated with 
different treatments compared to Pff group. The results revealed that 120, 55, and 167 genes 
were differentially expressed in matured oocytes for NE, CA, or CANE, respectively. The data 
were analyzed using EASE program to classify genes into different ontology categories. While 
DAVID and PANTHER programs were used to identify the most significant molecular pathways 
induced by each treatment. The results showed CA treatments significantly up-regulated 
mitochondrial ribosomal protein L3 ( MRPL3) and heat shock protein 90kDa alpha (HSP90AA) 
genes. Also, Janus kinase / signal transducer and activator of transcription (JAK/STAT) and 
Platelet-derived growth factor (PDGF) pathways were up-regulated. The NE treatments up-
regulated several genes: MYC associated factor X (MAX), mitogen-activated protein kinase 9 
(MAPK9), and v-rel reticuloendotheliosis viral oncogene homolog (REL) involved in cellular 
proliferation and the development of oocytes. While CANE was found to up-regulate IGF1 gene. 
The results of this study showed that using different substances to delay meiotic resumption 
would change the response of molecular pathways and genes expression of matured oocytes. 
However, the effects of these treatments groups on embryo development were equivalent to Pff 
group. 
In our final study (Chapter 5), in vitro produced pig embryos were vitrified using two different 
devices: a closed device (French Straws (FS), n=127) or an open device (Open Pull Straw (OPS), 
n=115). After vitrification and warming, the embryos were graded based on their morphological 
quality and cultured for 48 hrs. The quality of embryos was also evaluated at 48 hrs of embryo 
culture. The results showed that almost 85% of the vitrified embryo were quality 1 after the 
warming procedure for both devices. However, the quality of embryos (Grade 1) slightly 
decreased in OPS compared to FS after 48 hrs of culture (FS=88, OPS=72). Vitrified-warmed 
embryos did not grow from morula to blastocyst, suggesting sub-optimal culture conditions or  
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cryo-damage affecting the development of embryos. These results indicated that using FS in a 
vitrification protocol can be used to preserve in vitro produced pig embryos on long-term basis.  
This thesis was demonstrated that delaying meiotic resumption of pig oocytes using 
NPPC+estradiol, cAMP or NPPC+estradiol+cAMP treatments can support embryo development 
by improving oocyte competence through different molecular effects. Also, these in vitro  
produced embryos could be stored in liquid nitrogen in a closed devices (French Straw). 
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CHAPTER 1 
1.0 LITERATURE REVIEW 
1.1 Introduction 
Pork is the world’s most consumed meat and accounts for over 36% of global meat intake [1]. 
However, the Food and Agriculture Organization of the United Nations (FAO) report (2013) 
indicates that 23% of worldwide pig breeds are at risk of extinction, and indeed 109 breeds are 
already extinct [2]. This fact highlights a significant threat to genetic diversity, especially given 
that most of current pork production comes from just a few domestic breeds [3]. For this reason, 
many countries, including Canada, have committed to protect the genetic diversity of different 
species by preserving their genetic material as sperm, oocytes, tissue, or embryos [4]. Thus, 
assisted reproductive technology, including in vitro embryo production, is being used as a tool to 
mature oocytes or produce embryos needed for preserving or improving animal breeds. 
In vitro embryo production (IVP) has been widely used to generate a vast number of viable  
embryos for biotechnical manipulation or commercial purposes in farm animals [5]. The IVP 
technique has three independent steps: In vitro maturation (IVM), in vitro fertilization  
(IVF), and in vitro culture (IVC) [6]. The in vitro embryo production technique has been applied  
to different mammalian species to gain many advantages including: improving the genetics of 
the herd, controlling disease outbreaks, and preserving embryos for the long term (gene 
banking). Although IVP has been progressively developed over three decades [7], the efficiency 
of using this technique is still low in pig compared to the use of IVP in cattle or mouse [6]. In 
pigs, the IVP procedure still faces certain problems that have remained unsolved over the years, 
such as insufficient oocytes maturation, a high incidence of polyspermy (oocyte fertilized by 
several spermatozoa) and low embryo development [8, 9].  
One of the main reasons for the low developmental competence of in vitro- produced embryos is 
the poor cytoplasmic maturation of oocytes during in vitro maturation (IVM) [6, 9]. To 
overcome this problem, temporary inhibition of meiotic resumption during the first stage  of the 
IVM period (first 20-22 hours) could synchronize the progress of maturation and improve oocyte 
competence [10-12]. During meiotic arrest, protein synthesis continues in the oocytes [13] to 
accumulate factors in the cytoplasm to support embryo development, through communication 
with the cumulus cells. For this reason, many substances inhibiting meiotic resumption 
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(including dbcAMP, roscovitine and butyrolactone) have been used to improve cytoplasmic 
maturation [13-15]. The temporary inhibition of meiotic activity can be achieved by suppressing 
the activity of the maturation promoting factor (MPF) [16] or by elevating the the intercellular 
level of cyclic adenosine monophosphate (cAMP) [10]. This research focuses on improving 
cytoplasmic maturation during in vitro maturation of pig oocytes with the ultimate goal of 
producing a sufficient number of competent embryos. 
 
1.2 Oocyte development and its competence 
Oogenesis is a process of development of germ cells into primary oocytes, secondary oocytes 
and finally ovum [17]. This process starts when the primordial germ cells migrate from the yolk 
sac to gonads, where they multiply from a few thousand of cells to millions [18]. In pigs, germ 
cell meiotic division continues from day 13 of embryonic life until day 7 following birth [19]. 
Proliferating germ cells are called oogonia that differentiate into primary oocytes. Meiosis in 
pigs begins in oogonia during early embryonic life (Day 40) and stops around 35 days after birth 
when all oogonia arrest in the prophase of the first meiotic division (germinal vesicle, GV) [19, 
20]. The transition from meiotic to a meiotic program is regulated by various factors and signals 
coming from the somatic cells around the oocyte [21]. The structure of the primary oocytes are 
enclosed by a single layer of flattened pre-granulosa cells, which the complex is referred to as 
primordial follicles [22]. When the granulosa cell appearance changes from flat to cuboidal, the 
primordial follicle becomes primary [18]. During secondary follicle development, the oocytes 
grow, and the number of granulosa cell layers increases. Finally, the antral follicle (tertiary 
follicle) is marked by the formation of fluid-filled cavity, called antrum [23]. Most of oocytes 
collected from follicles of a size between 3-8 mm can reach to metaphase II (MII) [24]. During 
folliculogenesis, size of pig oocytes grow from 20 to 160 µM [25], and many structural changes 
occur in the oocytes that make the oocytes competent (matured) for fertilization and embryo 
development [6, 19]. The maturation of oocytes is done on two levels: cytoplasmic and nuclear 
maturation. These two levels of maturation are explained in the following section. 
 
1.2.1 Nuclear maturation 
Nuclear maturation can be identified as the ability of the oocyte nucleus to develop from the GV 
stage to metaphase II of meiosis [26]. There is a positive relationship between the diameter of the 
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follicle and the meiotic activity; follicles of diameter < 3mm are generally incompetent to 
progress in pigs [27]. 
In general, oocytes from a majority of mammalian are arrested after birth in prophase I of 
meiosis I until puberty [28, 29]. However, the oocytes resume meiosis spontaneously when they 
are removed from the follicles and introduce in an in vitro envrionment [30]. The nuclear 
maturation process has been classified based on the morphological changes that take place in the 
chromosome during meiosis. Before meiotic resumption, oocytes contain diffuse chromosomes 
that are enclosed within the intact nuclear structural cell that is referred to as the germinal vesicle 
(GV). At meiotic resumption, the chromosome begins to condense and GV breaks down 
(GVBD); the nuclear membrane almost disappears. GVBD leads to diakinesis where the 
chromatin undergoes condensation into either a single lump or smaller discrete fragments [31, 
32].  
As maturation progresses, metaphase I starts to align with the paired homologous in the middle 
of the forming meiotic spindle. As meiosis proceeds to anaphase I (ana I), the bivalents of the 
chromosomes separate and start to move to opposite poles of the cell due to the action of the 
spindle. The separation (telophase I) is resulting in two diploid daughter cells, namely, the first 
polar body and the oocyte. By metaphase II, the polar body chromosomes begin degradation 
while the chromosomes of the oocyte are arranged on the meiotic spindle [33, 34]. At this stage, 
the meiotic division I is finished, and the oocytes are ready for fertilization. After sperm cells 
penetrates the zona pellucida and one sperm cell enter into the oocyte,  meiosis II  resumes by a 
transaction from MII to ana II, leading to a release of the second polar body. The sperm nucleus 
condenses, and two haploid nuclei are formed (male and female pronuclei) in the fertilized 
oocyte [26].  
In vivo, it was found that injecting pigs with hCG led to GVBD in about 18 hrs after 
gonadotropin exposure and meiosis was completed (MII) by 36-40 hrs [35]. In vitro, the nuclear 
maturation can be achieved (MII) in the pig oocyte in a time ranging from 36-48 hrs [36, 37]. 
Although the rate of nuclear maturation in vitro is high and almost similar to that in vivo, the 
number of oocytes that develop to the blastocyte stage are often small (< 30%) in pigs [36, 37]. 
This fact indicates that oocyte competence during in vitro maturation relates more to cytoplasmic 
maturation than to nuclear maturation. 
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1.2.2 Cytoplasmic maturation 
Cytoplasmic maturation can refer to all molecular and ultrastructural changes in oocyte 
cytoplasm supporting the developmental competence of the oocytes [38-40]. During cytoplasmic 
maturtion, oocytes accumulate mRNA and proteins [40, 41]. Proteins that are expressed from 
mRNA have a significant role in oocytes maturation, fertilization and early embryonic 
development [42, 43]. Cytoplasmic maturation can be considered as significant factor that affect 
matured oocyte to undergo normal fertilization and blastocyst formation. Therefore, the level of 
embryo development (cleavage and blastocyst rate) can reflect the cytoplasmic maturation 
condition indirectly.  
The Intracellular glutathione (GSH)  plays an essential role in protecting cells against oxidative 
stress and maintaining intracellular redox status [44]. Also, GSH concentration increases during 
oocyte maturation and is involved in male pronucleus (MPN) formation that coincides with 
oocyte activation [45]. In vitro, cysteine and cysteamine (GSH precursors) have been used in 
maturation media and have been shown to improve the embryo developmental rate of a pig or 
bovine oocytes [46, 47]. Cumulus cells were found to participate critically in the GSH content of 
the oocyte [48] by supplying the cysteine to oocytes or produce and transport GSH to oocytes 
[8]. Supporting this role for cumulus cells, maturation of denuded oocytes did not improve their 
developmental competence [49, 50]. The GSH content of oocytes is used to evaluate cytoplasmic 
maturation [6, 51].   
Other important cytoplasmic maturation changes are cortical granule translocation and the 
intracellular calcium level [52]. During oocyte maturation, cortical granules migrate to the cortex 
of the oocytes and attach beneath the oolemma. After fertilization, the content of cortical 
granules are released into the perivitelline space to block polyspermy by modifying the oocytes. 
extracellular matrices [53]. This secretory process is calcium dependent and known as a cortical 
reaction [54]. The amount of calcium stored in the oocytes increases significantly in matured 
oocytes compared with those that are immature [55], showing the importance of calcium for 
oocytes activation.   
Mitochondria are other cytoplasmic organelles  
playing a key role in different cytoplasmic processes during oocyte maturation, as they are the 
main supply of energy [56, 57]. Mitochondria synthesize adenosine triphosphate (ATP). They 
are considered an internal source of Ca
2+
. The low mitochondrial content has been linked to the 
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failure of fertilization and abnormal embryogenesis [58]. During oocyte maturation, the pattern 
of mitochondrial distribution and its metabolic activity undergoes several changes [59]. Pig 
mitochondrial transfer from the peripheral part of the oocyte to the inner ooplasm of the cell [59, 
60]. It was also found that ATP content increased significantly during in vitro maturation [61] 
and had a similar amount in those pig oocytes that were matured either in vivo or in vitro [56]. 
The endoplasmic reticulum (ER) also undergoes significant changes during oocyte maturation. 
The membranes of ER have many known functions, including: lipid metabolism, protein folding 
and degradation, compartmentalization of the nucleus, and membrane synthesis [62]. Further, 
regulating the intracellular releases of calcium is an important structural change in the ER during 
maturation and has an essential role in oocyte activation [63, 64]. In porcine oocytes, the ER 
distributes throughout the cytoplasm from the GV to the MI stage of oocyte maturation. 
However, at the MII stage, the ER produces uniquely large clusters at the animal pole of the 
cytoplasm, around the first polar body [65].  
1.2.3 Control of oocyte meiotic arrest 
Fully grown oocytes are maintained in meiotic arrest (Prophase I) within the antral follicle until 
meiosis resume when the LH surge occurs. However, cumulus oocyte complexes (COCs) resume 
meiosis spontaneously when COCs are removed from follicles and cultured [30]. This 
observation indicates that the meiotic arrest process is controlled by several factors that  exist in 
follicular fluid and are secreted from mural granulosa cell origin [66]. These factors were shown 
to act on cumulus cells and were blocked by LH [66, 67]. Many studies have identified 
intracellular and paracrine interaction factors between oocyte and somatic cells that are involved 
in the meiotic arrest [68-71]. One of the key components in maintaining the meiotic arrest 
process is cyclic adenosine monophosphate (cAMP) level in the oocytes [68, 72]. The high 
cAMP level suppresses the activity of the CDK/cyclin B protein complex, also known as 
maturation promoting factor (MPF) [71]. However, when the MPF is activated, meiosis 
resumption occurs. In the following section, most of the components that are involved in the 
meiotic arrest are explained.  
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1.2.3.1 cAMP:  
This secondary messenger plays a regulatory role in the meiotic oocyte cycle. The cAMP is 
synthesized by adenylate cyclase (ADCY) under the control of gonadotropins (FSH and LH) 
[73]. Also, cAMP is considered as a regulator for gap junctional communication [74]. 
Decreasing the level of cAMP is a signal to resume meiosis. There are two mechanisms that 
elevate the cAMP level and maintain the meiotic arrest. For a long time, it was believed that the 
majority of intra-oocyte cAMP is generated by granulosa cells and diffused into the oocytes 
through gap junctions from the cumulus cells [75]. However, some studies in rodent and human 
have indicated that the oocytes themselves can generate cAMP to maintain meiotic arrest by G-
protein coupled receptors (GPR3 and/or GPR12) and stimulate ADCY [69, 76, 77]. It was 
observed that mice oocytes having a deficiency in ADCY or GPR3-knockout resumed meiosis 
spontaneously [78, 79]. Also, when porcine oocytes were cultured with forskolin, cAMP 
production increased by stimulation of ADCY production [80]. These results indicate that the 
GPR/ADCY pathway in oocytes could be an essential for cAMP production [71]. In pigs, GPR3 
is found to be essential for maintenance of meiotic arrest in oocytes, through the pathways 
involved in the regulation of cAMP [81]. A second regulator for cAMP level in oocytes is a 
phosphodiesterase 3A (PED3A) enzyme that is involved in the hydrolysis of cAMP to 5-AMP 
[82]. PED3A has been located only in oocytes [69]. Suppressing PED3A activity is required to 
prevent cAMP degradation and to maintain a high level of cAMP in the oocytes. Cyclic 
guanosine monophosphate (cGMP) is responsible for inhibiting PED3A activity [83, 84]. The 
cGMP is synthesized in cumulus cells and it is moved to the oocytes through gap junctions [84, 
85]. It has also been reported that PED3A is downstream of GPR3 in the regulation of the cAMP 
level in the oocytes [86]. The concentration of cAMP in oocytes is controlled by its degradation 
(PED activity), rather than by endogenous synthesis [87]. In GPR3 knockout mice, it was found 
that the spontaneous progression of meiosis was blocked by an injection of GPR3 RNA into 
preantral follicle-enclosed oocytes, followed by culture to the early antral stage [79]. 
Various chemicals have been used to elevate the intracellular level of cAMP in maturation 
media: dibutyl cyclic adenosine monophosphate (dbcAMP) and cycloheximide [88, 89]. Most of 
these chemicals increase the level of cAMP depend on two mechanisms: stimulating the ADCY 
enzyme or inhibiting the PDE3A enzyme. More details will be discussed in section 1.5.1 for the 
in vitro method to increase the intracellular level of cAMP. 
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1.2.4.1.1 How do high cAMP concentrations in the oocytes prevent meiotic resumption? 
The major component that regulates the activity of the maturation promoting factor (MPF) in 
oocyte is protein kinase A (PKA). A study in mouse oocytes observed the inhibition of PKA-
induced GVBD in oocytes [79]. Therefore, PKA is considered the mediator of cAMP activity in 
oocytes. However, the effect of PKA is not directly on MPF (CDK1/cyclin B complex), but it 
regulates through the activity of Wee1/myclin transcription factor 1 (Wee1B/MYT1 kinase) and 
cell division cycle (Cdc25B) phosphatase [90]. The high level of cAMP in oocyte stimulates 
PKA, which activates Wee1B to produce phosphorylated CDK1 leading to inhibition of CDK1 
[71]. As a result, inactive CDK1 inhibit the MPF. It was found that Wee1B mRNA expression 
increased in oocytes during the GV stage and it down-regulated in early meiosis resumption in 
both in vivo and in vitro maturation [91, 92]. On the other hand, high PKA level inactivated 
Cdc25B (diphosphatase CDK1) by phosphorylation serine residue at position 321 [93]. When 
Cdc25B is inactivated, it is transferred from the nucleus to cytoplasm, away from the 
phosphorylation activity of CDK1 in nucleus [94]. Therefore, the MPF complex becomes 
inactive and the oocyte is maintained at the GV stage. At the time of meiotic resumption, the 
PKA activity decreased leading to activation of Cdc25B, removing the inhibitory 
phosphorylation caused by Wee1B. Then, CDK1 is activated which stimulates the MPF (Fig.1.1; 
the description is based on a review from Liu et. al. [82]).  
 
1.2.3.2 Natriuretic peptide precursor Type C (NPPC):  
The natriuretic peptide system family has three types of structurally related forms: The 
natriuretic peptide precursor type A (NPPA), natriuretic peptide precursor type B (NPPB) and 
natriuretic peptide precursor type C (NPPC or CNP) [95]. NPPA and NPPB are mainly produced 
in atrial and ventricular cardiomyocytes, respectively [96]. NPPC is generated by mural 
granulosa cells, and its cognate receptor natriuretic peptide receptor 2 (NPR2) is located 
primarily in cumulus cells [97]. It has been shown that NPPC increases the intracellular cAMP 
concentration in mice COCs by promoting cyclic guanosine monophosphate (cGMP) production 
in the cumulus cells through its receptor NPR2 [97]. The cGMP is transferred to the oocytes via 
the gap junctions to inhibit the activity of PDE3A in the oocytes [69, 98, 99].  
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Fig. 1.1 Model of meiotic arrest in the porcine oocyte. Intra-oocyte cAMP is produced by G-protein 
coupled receptor 3 (GPR3) that activate adenylyl cyclase (ADCY) endogenous to the oocyte. The cGMP 
is transferred from cumulus cells inhibit phosphodiesterase (PDE) 3A activity and cAMP hydrolysis, 
maintaining cAMP levels high. The cAMP-dependent protein kinase regulates the activity of maturation-
promoting factor (MPF) by the phosphatase cell division cycle 25 (CDC25) and the kinases Wee1 and 
myelin transcription factor 1 (Myt1): CDC25 dephosphorylates cyclin-dependent kinase 1 (CDK1), 
whereas Wee1 and Myt1 phosphorylate CDK1. High cAMP levels result in the phosphorylation of CDK1 
and inactivation of the MPF complex (CDK1–cyclin B (CyB)) leading to maintaining the oocyte at the 
germinal vesicle stage. (Adapted from Liu et. al.[82]) 
 
By blocking the activity of PDE3A via a high level of cGMP, the concentration of cAMP  in the 
oocytes increased (Fig 1.2), leading to the arrest of meiotic resumption. In a study on mouse 
oocytes, adding NPPC (100 nM) to the maturation media inhibited resumption of meiosis 
(GVBD rate 98% in control vs <10% in the treatment group) [97]. The expression of NPPC in 
mural granulosa cells has been found to be stimulated by FSH receptors activated by equine 
chorionic gonadotropin (eCG) [100, 101]. In addition, eCG treatments increased NPR2 
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expression in cumulus cells [102]. In vitro, FSH did not show the same in vivo effect on NPR2 
mRNA expression in the cumulus cells [100]. This observation may indicate that the FSH effect 
is indirect on NPR2 expression [82].  It was found that using NPPC plus estradiol or testosterone 
inhibited the meiotic resumption significantly in mouse oocytes compared to NPPC alone [100]. 
Interestingly, the same study showed that testosterone and estradiol increased the mRNA 
expression of NPR2. In this specific pathway, the oocytes may play an important role by 
producing many oocyte factors, such as growth differentiation factor 9 (GDF9) and bone 
morphogenetic portion 15 (BMP15) or fibroblast growth factors 8 (FGF8) [69, 97]. These 
oocytes derived paracrine factors (ODPF) increased the expression of NPPC and/or NPR2 via 
the stimulation of estradiol production [103, 104]. This pathway may demonstrate a type of 
control mechanism for the oocytes to maintain the meiotic arrest (Fig. 1.2). Therefore, NPPC and 
its receptors (NPR2) are thought to play a critical role in the maintenance of the meiotic arrest, 
producing a high level of cGMP and increasing the cAMP level in oocytes.   
 
1.2.3.3 Nitric oxide (NO):   
Nitric oxide is a short-lived messenger that  involves in a variety of physiological functions 
including a regulatory role in the nervous, immune, and cardiovascular system [105-107]. Also, 
NO plays a critical role in many reproductive events such as ovulation, oocyte meiotic 
maturation, and fertilization [108, 109]. The nitric oxide synthase (NOS) synthesizes NO in cells 
using L-arginine and oxygen [110]. There are three forms of NOS: Neuronal NOS (nNOS), 
endothelial NOS (eNOS), and inducible NOS (iNOS) [111]. The iNOS and eNOS are found 
expressed in granulosa and theca cells [112, 113]. On the follicle, NO is essential for maintaining 
and increasing the rate of ovarian blood flow during the pre-ovulatory period [112]. Also, NO 
has a significant function before and during embryonic development [114].  
To study nitric oxide (NO) cellular responses, nitric oxide donors such as S-Nitroso-N-
acetylpenicillamine and S-Nitrosoglutathione have been used to stimulate physiological 
conditions resulting in the donation of NO [115]. Several studies have shown that NO donors 
inhibited rodent oocytes meiotic resumption [116, 117]. However, a NO donor can have the 
opposite action depending on the dosages [108]. In pig, culturing oocytes with a NOS inhibitor 
and NO donor inhibited the meiotic resumption of oocytes [118] or blocked meiotic maturation 
[119]. Interestingly, it was found that iNOS expression in granulosa cells decreased after eCG 
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injection, which indicated that the level of NO metabolism also decreases after eCG injection 
[120]. Another study found that using an iNOS inhibitor (L-NAME) decreased cGMP production 
in granulosa cells [121, 122].   
In general, the high level of NO can cause an inhibitory effect on meiotic resumption of oocyte 
in mice [123], rats [124] and pigs [118, 125]. The production of NO can be regulated by 
estradiol. A study of porcine oocytes found that adding estradiol to maturation media promoted 
the synthesis of NO without any increases in eNOS expression [126]. Soluble guanylate cyclase 
(sGC) is the main receptor for NO in cumulus cells. The sGC plays a significant role in the 
production of the cellular messenger molecule, cGMP [127]. Therefore, nitric oxide can be an 
important component in meiotic arrest as it increases the cGMP level and subsequently increases 
the level of cAMP to prevent meiotic resumption.  
 
1.2.3.4 Cyclic guanosine monophosphate (cGMP):  
This second messenger plays an activation role of intracellular protein kinases [128]. Increase of 
cGMP level in oocytes is associated with a delay of meiotic resumption [129], suggesting that 
cGMP have an inhibitory effect of nuclear maturation. Cumulus cells produce cGMP, and it is 
transferred through gap junctions to the oocytes [71, 89]. Increasing the level of cGMP-inhibited 
the PDE3A in the oocytes [130]. This inhibition of PDE3A would prevent cAMP degradation 
therefor keeping intracellular cAMP high in the oocytes to maintain the meiotic arrest. In vitro, 
porcine cumulus oocytes treated with cGMP analogs (0.1-1mM) during maturation inhibited 
meiotic resumption and increased significantly the intracellular level of cGMP [131]. Another 
study on porcine oocytes found that adding 5 mM of cGMP was enough to inhibit the meiotic 
resumption [132]. Also, it was found that treatment of the COCs with LH decreased the level of 
cGMP via activation of the EGF network [98]. These different observations demonstrated the 
regulatory function of cGMP on the meiotic arrest.  
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Fig.1.2 Mechanism of molecular pathways of nitric oxide (NO) and natriuretic peptide protein type C 
(NPPC) in a cumulus-oocyte-complex maintaining meiotic arrest. NPR2: natriuretic peptide receptor 2, 
sGC: Soluble guanylate cyclase, MPF: Maturation promoting factor, GTP:  Guanosine-5'-triphosphate, 
GPR3: G- protein coupled receptors, GV: Germinal vesicle, PDE3A: Phosphodiesterases 3A, 
AMP:Adenosine monophosphate and ODPF: oocytes derived from paracrine factors.  
 
1.2.3.5 Hormones (testosterone, estradiol, and progesterone): 
Steroid hormones were found in follicular fluid during oocyte maturation at different levels. 
These hormones play a critical role in oocyte modifications regarding nuclear and cytoplasmic 
level [133-135]. In a study on bovine COCs, adding aminoglutethimide to maturation media to 
block steroid hormone secretion negatively affected the cumulus cell expansion [135]. Steroid 
hormones (testosterone, estradiol, and progesterone) were found to be involved in different 
pathways of meiotic arrest. Estradiol increased production of many factors that inhibit meiotic 
resumption such as NPR2, NO and NPPC [100, 102, 136]. It is reported that the mRNA level of 
NPR2 increased when immature rats are treated with synthetic estrogen diethylstilbestrol [137]. 
Estradiol treatment also promotes expression of NPR2 at the mRNA level of mouse cumulus 
cells. The elevation in NPR2 expression leads to an increase of cGMP concentration in response 
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to NPPC and maintained meiotic arrest with NPPC treatment [100]. In another study, when 
porcine COCs were treated with estradiol (10 nM), NO production increased in comparison to 
progesterone and testosterone [126]. Testosterone treatment on mouse cumulus cells also 
increased NPR2 expression and meiotic arrest in vitro [100]. The testosterone action on NPR2 is 
likely due to the aromatization of testosterone to estrogen, rather than androgen action, 
supporting the fact that using dihydrotestosterone (non-aromatizable androgen) did not stimulate 
the expression of NPR2 [100]. Another study found that treatment of mouse oocytes during in 
vitro maturation with a high testosterone concentration (≥ 40 µM) inhibited meiotic resumption, 
while a low testosterone concentration could not prevent the inhibition of meiosis [138]. 
Testosterone was also found to increase the inhibitory effect of dbcAMP on meiotic resumption 
in porcine oocytes [139].  
 
1.3 In vitro embryo production (IVP) 
In vitro embryo production is a procedure consisting of three steps that allow for the production 
of embryos. In the first step, immature oocytes undergo a process called in vitro maturation 
(IVM). During this stage, the oocytes undergo many changes at a cytoplasmic and nuclear level 
to be ready for in vitro fertilization (IVF). In this step, the matured oocytes are incubated with 
spermatozoa to generate the zygote. The third process is in vitro culture (IVC). In this stage, 
presumptive zygotes are cultured in media and supplied with the necessary nutrients for normal 
embryo growth until the blastocyst formation [5].  
 
1.3.1 Importance of in vitro production of embryos 
Large scale  in vitro production of porcine embryo can  be derived from a significant number of 
oocytes from slaughterhouse derived ovaries. Therefore, IVP can produce a large number of 
viable embryos at a low cost compared to surgical embryo collection [47]. Embryos can be used 
for research in reproductive physiology including micromanipulation of embryos to provide 
genetically modified swine as potential donors of tissues and organs [5]. The IVP of pig embryos 
can be utilized to address various economic traits, such as growth rate and food efficiency, and to 
increase productive efficiency and the rate of genetic gain [140]. In addition, the availability of 
embryos can enhance the biosecurity of the swine industry by decreasing the use of live 
replacement animals. The high cost and the risk of disease transmission that is associated with 
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live animals also make the use of the embryos favorable [141]. However, the high cost of 
surgical transfer of embryos has limited commercial applications. Successful cryopreservation of 
pig blastocysts [142] and embryo transfer of rare pigs breeds [143] highlights the importance of 
IVP in gene banking of a rare or valuable breed. Cryopreservation of pig embryos could be 
considered as a protective measure against disease outbreak. Genetic material can be stored for 
lengthy periods to protect the breed from extinction and to maintain genetic diversity. IVP can 
also be used to stimulate research on factors controlling embryonic development and to identify 
factors to prevent significant economic losses due to the high rate of early embryonic mortality 
[144].  
 
1.3.2 In vitro maturation (IVM)  
Oocytes collected from ovaries obtained from slaughtered animals are immature regarding 
nuclear and cytoplasmic maturation. During the IVM process, the oocytes are exposed to specific 
media for 40-44 hrs to resume the meiosis until metaphase II (MII) and to prepare them for 
fertilization [6]. During this period, the cytoplasm undertakes many structural changes that are 
critical for subsequent embryo development. The maturation medium contains many 
supplementations (such as hormones, growth factors, and follicular fluid [145]) to promote 
cytoplasmic and nuclear maturation.  
Many morphological criteria need to be considered in selecting follicles, COCs or oocytes. There 
is a positive relationship between follicle size and oocytes developmental competence [24]. 
Oocytes that are collected from the small follicles (< 3 mm) are less competent to support 
embryo development, while the oocytes of medium follicle size (3-8 mm) have increased 
likelihood [146]. Most IVM protocols recommend harvesting follicles from 3-6 mm in size for 
pig ovary [147]. Cumulus cell layers surrounding the oocytes represent another important 
parameter that correlates with oocytes competence. As previously discussed, cumulus cells 
supply the oocytes with many signals and molecules required for oocytes maturation [148]. It is 
recommended to select COCs with at least three layers of cumulus cells [8]; thicker layers could 
reflect more competent oocytes [149]. At the end of IVM, cumulus cell expansion can be used as 
an indicator of full maturation of oocytes [148].  
Different maturation media have been used in various laboratories such as TCM-199 [37], 
NCSU-23 [150], and POM [151]. Most of these media aim to have same of  in vivo conditions as 
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much as possible. In general, most maturation media are supplemented with gonadotropins (LH, 
FSH). These hormones are required to stimulate meiotic resumption and other oocytes functions. 
FSH activates cumulus expansion and supports nuclear and cytoplasmic maturation [152]. It also 
induces the expression of factors such as hyaluronic acid and cAMP that control many functions 
in oocytes [153]. The actions of FSH mainly takes place indirectly on oocytes via granulosa cells 
[154]. The in vitro role of LH is controversial, as some reports indicating that LH receptors in 
cumulus cells were not present in cattle [155, 156]. However, LH receptor expression in cumulus 
cells in pig was reported [157-159]. As LH plays an important role in oocyte maturation, most 
the IVM procedures include this gonadotrophin in their maturation media. Growth factors are 
also added to IVM media, such as epidermal growth factor (EGF) [160], and essential and 
nonessential amino acids [161].  The main beneficial effect of EGF is activation of the synthesis 
of intracellular glutathione supporting embryo development and protecting DNA [162].    
1.3.3 In vitro fertilization (IVF) 
In vitro fertilization is a process that incubates matured oocytes and spermatozoa to allow 
fertilization. When spermatozoa are exposed to culture media, many morphological and 
biochemical changes occur in the sperm to prepare them for fertilization, defined as capacitation. 
However, successful IVF depends more on the preparation procedure for spermatozoa [163], 
oocytes and the interactions of sperm-oocyte. Co-culture of porcine oocytes with oviductal 
epithelial cells have also elevated the percentage of monospermic oocytes [164]. These results 
indicated that a factor(s) from the oviductal fluid is important for the maintenance of 
monospermic fertilization penetration. Therefore, many aspects of the IVF protocol were 
considered regarding polyspermy and the different protocols were modified to minimize such 
effects.  
Many elements are integral to a successful IVF procedure including sperm-oocyte incubation 
time, IVF media conditions, and sperm concentration. A study evaluated sperm-oocyte 
incubation periods ranging from 3 to 12 hrs; they found that 6 hrs was the optimal incubation 
time based on a maximal penetration rate (81%) with polyspermy around 39% [165]. As 
incubation time increased, the number of polyspermic presumptive zygotes increased with no 
change in penetration rate [166]. Therefore, it is recommended to incubate spermatozoa with 
oocytes for 6 hrs [165, 167]. However, another study found that 6 hrs of incubation with sperm 
can increase the number of sperm cells into the oocyte compared to 3 hrs incubation [168]. 
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Incubation of sperm with oocytes over a short time (10, 30, 60 min) compared to 6 hrs did not 
improve embryo development or reduced the rate of polyspermy [169]. 
Different types of fertilization media mimicking an in vivo system have been used in porcine IVF 
such as: modified tris buffer medium (mTBM), Tyrode’s medium (TALP), and IVF medium-199 
(IVFm-199) [5]. A fertilization medium is needed to support the physiological functions of both 
oocytes and spermatozoa. Bovine serum albumin is an important component in IVF media to 
induce capacitation and to regulate penetration of the sperm in the oocyte [165, 170]. However, it 
could increase the mean number of sperm per oocytes [165]. Extracellular calcium is also 
required in IVF media because of its role in capacitation and maximal acrosomal exocytosis 
[171]. Caffeine is another common component used in IVF media. It has a role in sperm 
capacitation and a positive effect on embryo development [172].   
 
1.3.4 In vitro culture (IVC) 
The final step for in vitro embryos production is in vitro culture. The presumptive zygotes grow 
in an environment (5% O2, 5% CO2, and 90% N2) [173] that mimic in vivo conditions for 
embryo development. The culture medium contains many supplements that support embryo 
development. Most culture media contain different types of salts at a low concentration [174] 
and energy resources such as glucose [173]. Increasing NaCl concentration (94.88 vs. 68.49 
mM) in a culture media impaired embryo development compared to media with a lower NaCl 
concentration (respectively 20 and 10 vs.13% and 73% for morula and blastocyst, respectively) 
[174]. The pattern of energy resource available in a culture media can make differences in the 
results of embryo development. In a study, culture media was supplied with pyruvate and lactate 
for the first two days and then replaced with glucose for another four days [173]. The results of 
this study improved the blastocyst rate in an in vitro porcine system. Another study found that 
increasing the time using pyruvate and lactate from 48 to 58 hrs before replacing the media with 
glucose was more beneficial for blastocyst formation (20.6 vs 31.3% reparctively) [175]. Using 
glucose during the first two days of IVC was found to generate reactive oxygen species (ROS), 
which could induce apoptosis and provoked adverse effects on embryo development [176]. The 
addition of amino acids to culture media also improved embryo development in pig [177]. 
Taurine and/or hypotaurine into culture media has been shown to significantly enhancing the 
development of porcine embryos [178]. Also, supplementation of culture medium with oviductal 
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fluid supports embryo development [179]. Since the availability of oviductal fluid is limited in 
general routine embryo culture,  most labs use  BSA as a protein supplement [150], and to 
maintain osmotic balance and stable PH [180]. BSA has been shown to improve the development 
of porcine embryos [181]. Adding insulin or leptin to a could be beneficial for the embryo 
development during IVC. Lee et al. [182] reported that supplementing culture media with insulin 
to a culture media improved the blastocyst formation rate (34.1 vs. 23.1% in control). The 
blastocyst formation rate was also significantly elevated (two fold) when insulin was used during 
IVM and IVC (40.4% compared to 21.2% for untreated group). Using leptin (100 ng/ml) in 
culture media significantly increased the rate of blastocyst formation compared with other leptin 
concentrations or control (no supplement) [183]. 
Different types of culture media have been used for porcine embryonic culture, including 
modified Chatot, Ziomek, Bavister (CZB) [184], Beltsville embryo culture medium (BECM)-
3[185], and PZM-5 [186]. One of the most popular culture media that has been used in porcine 
IVC is NCSU-23 [5]. This media was developed by North Carolina State University [150] and 
NCSU-23 was designed to meet the metabolism and nutrient requirements of pig embryos. A 
combination of NCSU-23with BSA was found to enhance blastocyst formation compared to 
other culture media [187]. Although NCSU-23 is the most commonly used media, some studies 
indicated that porcine zygote medium 5 (PZM-5) is more efficient in supporting the embryo 
development [151, 161]. PZM-5 is based on oviductal pig fluid compenents [186]. In summary, 
the success of IVC depends on the efficiency of the IVM/IVF process and its environment to 
culture embryos.  
 
1.4 Challenges in IVP of pig embryos 
Although the IVP technique has been progressively developed over three decades, the efficiency 
of IVP in pigs is still low compared to IVP in cattle or mouse [7]. In pigs, the IVP procedure still 
faces many problems that have remained unsolved over the years, such as insufficient 
cytoplasmic maturation, a high incidence of polyspermy and low embryo development. These 
problems are considered to be the main factors decreasing the efficiency of IVP in pigs [6] and 
these issues will be described briefly in the following sections. 
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1.4.1 Problems with in vitro maturation (IVM) 
Having sufficient nuclear and cytoplasmic maturation of the oocytes is key to successful 
fertilization and embryonic development [188]. Nuclear maturation represents all changes at the 
chromosomal level, from the resumption of meiosis to reach MII stage. Generally, oocytes are 
collected from ovaries of slaughtered animals of different ages, different estrous cycle stages, 
and with variable follicular sizes. Therefore, these oocytes have different developmental stages. 
This situation creates heterogeneity in the level of nuclear and cytoplasmic maturation among the 
collected oocytes, and some oocytes could start meiosis earlier than others during IVM [189]. 
The variation of in vitro development of oocytes may reflect an imbalance of nuclear and 
cytoplasmic maturation rates within the cell [190]. Interestingly, the rates of in vitro and in vivo 
nuclear maturation did not differ [31]. In this study, oocytes were collected from gilts (in vivo) to 
evaluate the change of GVBD at particular times after hormone treatment (PMSG and HCG); 
while in vitro, oocytes were collected from the same group of gilts and cultured in the medium. 
The interval time to evaluate GVBD in oocytes in vitro was similar to in vivo group. In general, 
most IVM media that used to mature pig oocytes, such as NCSU-23, has ability to support 
oocytes reaching final nuclear maturation (MII) [191]. Consequently, it is believed that 
cytoplasmic maturation is the main factor of variation in the maturation of oocytes [6]. Low level 
of cytoplasmic maturation of oocytes negatively affects the accumulation of mRNA, proteins, 
substrates and required nutrients to support embryonic development [192]. One study found that 
insufficient cytoplasmic maturation is partially responsible for low MPN formation and 
blastocyst formation [9]. 
Cumulus cells play a crucial role in cytoplasmic maturation through providing many factors that 
are needed for cytoplasmic reorganization [8]. During cytoplasmic maturation, different 
components of the oocyte (such as mitochondria, golgi apparatus, cortical granules and 
endoplasmic reticulum) undergo structural changes [62]. It was hypothesized that oocytes 
accumulate sufficient amount of stable mRNA that play an important role in final molecular 
maturation [193]. Stored mRNA and translation at specific sites of the cytoplasm was found 
involved in many maturation process such as cell motility and development mechanisms that 
play role in oocyte competence [42]. These mRNAs play a significant role in different synthesis 
types of proteins involved in subsequence fertilization and embryonic development. These 
proteins are stored until the activation of the embryonic genome [194]. Also, many factors can 
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affect the quality of oocytes during the IVM process. The age of the slaughtered pigs is a 
significant factor. Many studies have shown that oocytes derived from pre-pubertal donors have 
a lower blastocyst development rate than adult donors [195]. The number of layers of cumulus 
cells surrounding the oocytes and the size of the follicle is also essential for supporting the 
maturation during IVM. Oocytes surrounded with > 3 layers of cumulus cells in IVM have 
higher cleavage and blastocyst rates compared to oocytes with < 3 layers [196]. Furthermore, the 
quantity of lipids in the cytoplasm during IVM plays a significant role in normal embryo 
development and successful embryo cryopreservation [11]. Pig oocytes contain a high level of 
lipids [197]. During IVM, the inhibition of fatty acid oxidation in the pig oocyte was found to 
impair embryo development, which indicated the importance of lipid metabolism [198]. To 
summarize, the main problem for IVM is related to poor cytoplasmic maturation that negatively 
affects embryo development in later stages. 
 
1.4.2 Problems with in vitro fertilization (IVF) 
The most challenging obstacle in IVF of porcine oocytes is the high incidence of polyspermy 
[199]. This problem can be caused by insufficient fertilization conditions and/or inadequate 
maturation of the oocyte leading to embryonic death [200, 201]. The incidence of polyspermy 
can reach 30-40% in vivo for matured oocytes and this rate increases to 65% with in vitro 
matured oocytes [199]. Many factors affect the incidence of polyspermy during the IVF process, 
including the degree of maturation of the oocyte [202], and the quality and the quantity of semen 
used in IVF [203]. 
It is believed that the high incidence of polyspermy can increase when oocytes do not reach an 
adequate level of competence, leading to delaying the release of cortical granules [204]. It has 
been shown that the membrane of the oocyte changes during the maturation process [205].  The 
zona blockage (to prevent extra sperm from penetrating the zona pellucida) becomes slower, 
allowing for more sperm to reach the oocyte [206]. Furthermore, the morphological appearance 
of zona pellucida of oocytes derived from IVM is different compared to ovulated oocytes [166]. 
The diameter and the thickness of the zona pellucida are bigger for in vivo matured oocytes 
compared to in vitro matured oocytes [207]. These observations indicate that the maturation 
associated with zona pellucida is not fully achieved in IVM oocytes [206], which could lead to a 
high rate of polyspermy. Furthermore, some additives to the IVF media can increase the rate of 
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polyspermy. Culturing porcine oocytes and spermatozoa in media containing caffeine increase 
the rate of polyspermy [208]. Also, it was found that the acrosome reaction occur faster, and 
polyspermy rate was higher in mTBM compared to TALP or IVFm-199 [209]. The penetration 
and cleavage rates were lower with mTBM than other media [209]. Another observation is that 
the ability of sperm cells to penetrate oocyte can change according to the boar [210]. In 
summary, polyspermy is the major issue associated with IVF. 
 
1.4.3 Problems with in vitro culture (IVC) 
Many obstacles that exist in the IVM and IVF processes are reflected in embryo developmental 
competence in terms of the blastocyst formation rate and cell number [6]. During the IVC period, 
the DNA fragmentation rate of blastocysts and apoptosis of cells are increased [211]. It was 
found that embryos that grown in IVC media had a lower number of nuclei and cell division 
compare to embryo growing in vivo conditions [187, 212]. Low cell numbers in blastocyst were 
associated with an increased embryonic mortality and decreased pregnancy rate [213]. Levels of 
supplements in the culture media can also critically affect embryo development. For example, 
Beckman and Day [174] observed an increase of embryo development (84% morula and 
blastocyst) when the NaCl concentration was higher in the culture media compared to lower 
concentrations (3% morula and blastocyst). Culture media can alter embryo development 
potential [214], the ultrastructural morphology [215], and transcript abundance [216]. In 
summary, IVC faces problems due to obstacles encountered in previous stages (IVM and IVF).  
 
1.5 Importance of delaying meiotic resumption during in vitro maturation 
Poor cytoplasmic maturation is one of the biggest obstacles to improving the results of IVP of 
porcine embryos. In bovine COCs, a study found that the breakdown of gap junctions occurs 
earlier in vitro compared to in vivo conditions (respectively 3 hrs vs. 9-12 hrs after the peak of 
LH) [217]. These results indicated that the time available for oocytes to accumulate many 
important factors and nutrients [8] could be less in in vitro compared to in vivo conditions. The 
gap-junctional communication between oocytes and cumulus cells decreased significantly after 
gonadotropin stimulation that leads to meiotic resumption [218]. A positive correlation (r = 0.99, 
P<0.01) was reported between proportion of pig oocyte undergo meiotic resumption and COCs 
that lose gap junction [219]. Thus, the oocytes lose an important supplier of nutrients and factors 
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from cumulus cells playing an important role in cytoplasmic maturation. Furthermore, there is high 
variation in nuclear morphology of GV stage of pig oocytes obtained from slaughtered ovaries [220]. As a 
result, some oocytes will start meiosis earlier than other leading to heterogeneity in maturation status [10]. 
To overcome this problem, many studies have shown that temporary delaying the meiotic resumption 
during the first part of the IVM period (first 20-22 hrs) can synchronize the progress of maturation and 
improve the development competence of oocytes [10, 14, 189]. During the inhibition of meiotic 
resumption, protein synthesis continues in the oocytes [27], accumulating important factors (proteins, 
mRNA) in the cytoplasm through communications with cumulus cells. The temporary inhibition of 
meiotic activity can be achieved by using chemicals to elevate the intercellular level of cyclic adenosine 
monophosphate (cAMP) or to suppress the activity of the maturation-promoting factor (MPF). The 
following sections describes the different strategies to inhibit meiotic resumptions. 
 
1.5.1 Control of intracellular cAMP level 
Studies in different species have been used the strategy of increasing level of cAMP to prevent 
meiotic resumption and to improve the oocytes competence. Various agents increase the cAMP 
level by one of the four known mechanisms. First mechanism, the agents (such as dibutyryl 
cAMP (dbcAMP) and 8-Br-cAMP) has the ability to penetrate into the cumulus cells, and then 
enter oocytes through gap junctions. The most common chemical used for this group is dbcAMP 
due to its lipophilic nature that make it highly permeable to intact cells and resistant to hydrolysis 
by PDE3A[221, 222]. This cAMP analog has been used to maintain meiotic arrest in bovine 
[223], rat [224], mouse [225] and human [226] oocytes. In pig, many studies have used dbcAMP 
at a concentration of 1mM [139, 195, 227]. These studies used pre-pubertal porcine oocytes and 
they were treated dbcAMP for 20-22 hrs, at the beginning of the maturation period [14, 195].  
The results showed an increase in meiotic progression and blastocyst formation rate. In addition, 
this treatment decreases the incidence of polyspermy [10, 11, 14, 73, 189, 227]. The same 
treatment was also applied on pig oocytes obtained from sows and blastocyst formation did not 
change between treatment and control [195].  
The second way to elevate the cAMP level in oocytes is by the activation of adenylate cyclase 
(ADYC) in cumulus cells. Many chemicals work as activators for ADYC such as forskolin and 
cholera toxin [80, 228]. Forskolin has been used widely to inhibit the meiotic resumption in 
many species [223, 229, 230]. Recently, a study has evaluated the effect of forskolin on bovine 
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oocytes using different concentration (0.1, 0.05, 0.025 mM) for 6 hrs during IVM. Meiotic 
inhibition of oocytes with one of these treatment did not generate with the production of more 
blastocyst compared to control [231]. In pig, forskolin incubated with pre-pubertal porcine 
oocytes effectively inhibited the meiotic resumption during the IVM [80]. 
The third mechanism works by suppressing PDE activity, which induces the degradation of 
cAMP in oocytes. The 3-isobutyl-1-methyxanthine (IBMX) is a PDE inhibitor used to prevent 
meiotic resumption in bovine [223, 232], rat, and mouse oocytes [233]. In pigs, the addition of 
IBMX into the maturation medium for the first 20 hrs inhibited meiotic resumption and increased 
the level of cAMP in oocytes [234]. The fourth group increases cAMP level in oocytes by 
stimulating cGMP production in cumulus cells.  NPPC showed an ability to inhibit meiotic 
resumption in mouse [100]. Bovine oocytes treated with NPPC (100 nM) had a delay in meiotic 
resumption during IVM and an increase of blastocyst rate after fertilization of the treated oocytes 
[235]. In pig oocytes, NPPC was used in the second 22 hrs of IVM, after nuclear maturation of 
oocytes were synchronized with dbcAMP [236]. The results showed an inhibitory effect of 
NPPC increased significantly (P<0.05, GV rate from 20 to 60%) with an elevation NPPC 
concentration (10-1000 nM).  
1.5.2 Control of intracellular maturation promoting factors (MPF) level 
Meiotic resumption is promoted  by activation MPF [16]. The phosphorylation of CDK1 is 
considered as an essential step to activate MPF [90]. Many chemicals have been used to suppress 
the MPF activity and prevent meiotic resumption such as 6-dimethylaminpurine (6-DMAP, 
phospherylation inhibitor) [237], butyrolactone-I (BL-I, specific protin-kinase inhibitors) and 
roscovitine (ROS). BL-I has been used with porcine oocytes [238, 239] and bovine oocytes [240, 
241]. BL-I suppresses the activity of MPF by engaging the ATP binding site of CDK1, the 
catalytic subunit of MPF [242]. In a study on pig oocytes, BL-I was added to maturation media 
to delay meiotic resumption  for the first 24 hrs [243]. Although the results showed a delay in 
meiotic resumption, no positive effect was found on cleavage and blastocyst rates. Roscovitine 
also has been used to inhibit meiotic resumption in porcine oocytes via inhibition of cyclin-
dependent kinase (p34cdc2/cyclin B kinase) that suppress MPF activity [13]. In bovine, ROS 
was used in a combination with BL-I at a low dose and was found to delay meiotic resumption 
effectively without improving embryo development compared to control (untreated) [244]. 
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1.6 Communications between oocyte and cumulus cells 
Functions of granulosa and cumulus cells are regulated by factors secreted by the oocyte, such 
as: growth differentiation factor 9 (GDF9), bone morphogenetic portion 15 (BMP15) or 
fibroblast growth factors 8 (FGF8) [245]. BMP15 and GDF9 are members of transforming 
growth factor b (TGFb) superfamily that play a critical role in granulosa and cumulus cells 
functions [246]. Before LH surge, the BMP15 and GDF9 are produced by the oocyte. They 
stimulate normal differentiation of cumulus cells [247]. Also, BMP15 promotes metabolic 
activities in cumulus cells [248] and stimulates the cumulus expansion before ovulation [246]. 
Oocytes regulate estradiol synthesis by mural and cumulus granulosa cells [249, 250]. Estradiol 
increases the expression of NPR2 expression [100]. The communication between oocytes and 
somatic cells have a regulatory loop (Fig. 1.2) that play a significant role in oocytes maturation 
including meiotic progression and cytoplasmic competence.  
  
1.7 Porcine follicular fluid and defined medium  
Porcine follicular fluid (Pff) that is collected from the follicle (4-8 mm) is generally used in IVM 
media and it is effective at improving the results of embryo development [251, 252]. The porcine 
follicular fluid contains substances that improve the expansion of cumulus, nuclear maturation 
and normal fertilization [253]. Many components of Pff have been identified; however, some 
factors are still not known [254, 255]. For example, Pff contains a high level of superoxide 
dismutase that plays an essential role in the protection of oocytes against oxidative stress. 
Superoxide dismutase increases cytoplasmic maturation and oocyte competence [256].  
Many studies demonstrated the benefits of using Pff in the maturation media on nuclear and 
cytoplasmic maturation, normal fertilization, and embryo development [257-259].  The effects of 
Pff on oocytes competence depend on the size of follicles from which Pff was collected [260]. 
Pff collected from the large follicle in maturation media had a positive result on oocytes 
competence compared to using Pff from the small follicle [260]. Interestingly, it was observed 
that frozen Pff can improve the maturation and normal fertilization of porcine oocytes compared 
to fresh Pff in maturation media [253]. Although Pff supplement can have the positive effect on 
oocytes maturation and embryo development, there is a wide variability in the content of Pff 
obtained from different batches. This variability in Pff causes inconsistent results among studies 
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[261]. Also, Pff could be a carrier for a pathogen if the follicular fluid is collected from infected 
pigs [262]. A chemical based medium (defined medium, no Pff or serum) for IVM can help to 
standardize the media and identify specific metabolic requirements of oocytes with no risk of 
contamination. In addition, defined medium can contribute to achieve consistent results among 
laboratories. Many components have been used to replace Pff, including polyvinyl-alcohol 
(PVA) or poly-vinyl-pyrrolidone (PVP). These substances were used to prepare chemically 
defined media with TCM-199 [261] or modified NCSU-23 [160].Unfortunately, the results in 
both studies showed that using these defined medium can allow matured oocyte to develop into 
lower blastocysts rate compared of using Pff (Defined media vs Pff, 7.7% vs 23.3% [160]; 13% 
vs 22% [261]).  
 
1.8 Importance of using reproductive technologies in the commercial pig industry 
Successful pork production depends on the reproductive performance of the pig. Therefore, 
reproductive assistance technologies have become an essential tool in animal breeding to 
improve the productivity performance of swine [141]. In vitro embryo production, vitrification, 
and embryo transfer techniques can play an important role in improving pig productivity [263]. 
The ability to import and export pig genetic material around the world with minimum health 
risks would be valuable to the swine industry. Currently, semen (carry half-desired genetics) and 
live animals are the most common ways of handling genetic materials. Both methods are 
associated with a high risk of disease transmission [264]. However, embryos carry the full 
genome and are reportedly very low-risk for disease transmission [264]. Therefore, an in vitro 
embryo production technique could produce large number of viable embryos and it can have a 
significant role in breeding program with minimum costs when compared with embryos that 
collect in vivo. To make embryos practical for commercial work, cryopreservation using a 
vitrification technique is used to preserve embryos for short- or long-term use. Thus, 
reproductive techniques can have a critical role in developing and improving pork production 
when they are used to improve the genetic progress of pigs. 
Successful embryo transfer in combination with other reproductive technologies can significantly 
contribute to the genetic improvement in pig breeding programs through the ability to introduce 
new genetic stock as replacement herd animals[265, 266]. It was found that the ultimate impact 
of using biotechnology, including embryo transfer in pig breeding, can elevate the rate of 
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progress, efficient use of variation, and reduce genetic lag [265].  Globally operating breeding 
companies could also benefit from transporting embryos instead of live animals. One of the 
benefits of using embryos is the lower cost of transportation. Also, they can improve the 
biosecurity of embryos being transported between countries to minimize the risk of disease 
transmission  [267]. Therefore, using embryos and other reproductive techniques will be more 
preferable to ensure the health of herd status that represents a critical point in a successful pig 
industry [268]. The implantation of embryos derived from IVP technique with cloning can 
produce additional benefits for commercial pig populations [267]. Brascam and haley [263] 
suggested that using cloning to spread specific genotypes for particular markets can be applied at 
the level of the nucleus to become a source for cloning in these markets, such as daily growth 
rate and feed intake capacity. The other advantage of using embryos and vitrification techniques 
is the ability to preserve embryos of different pig breeds for the long term in order to maintain 
genetic diversity. Any future genetic improvements in pig breeding depends primarily on having 
sufficient genetic variation [269]. Genetic diversity can support pig breeds meeting current and 
future production requirements in different environment conditions. Consequently, this allows 
for sustained, economically important genetic improvement, as well as the ability to adapt 
breeding objectives rapidly [270]. Over last 50 years, many pig breeds (109 breeds) became 
extinct, and 23% of worldwide pig breeds are at risk of extinction [271]. Also, many studies have 
been reported o the risk of loss of genetic diversity in pig breeds [270, 272, 273]. These facts 
highlight the significant loss of genetic material globally. Therefore, preserving embryos (full 
genome) of different pig breeds will allow for maintaining genetic diversity or recreating extinct 
breeds [274]. As a result, genetic diversity strengthens a population by increasing variation, 
which allows for improving pig breeds to support pig production.  
Although using embryos derived from IVP in the pig industry has many benefits, there are also 
many limitations for applying this reproductive technique in commercial work. One of the most 
critical limitations is using surgical procedure for collecting and transferring embryos. Surgical 
procedures for commercial applications in the pig industry have only been used to a limited 
degree [275]. All surgical transfers or collections of embryos are performed under general 
anesthesia, and the animals need time for health care and recovery. Therefore, using embryos for 
commercial work is very limited in pigs [267]. Additionally, the cost of surgical procedures and 
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the need for specialists and high levels of training can be other obstacles for applying this 
procedure.      
One of the most key factors in the ability to use embryo transfer technology at a commercial 
level is the ability to collect and transfer embryos using procedures that can be applied under 
field conditions. Thus, many groups worked to find non-surgical methods to transfer the 
embryos, and the results of the attempts were variable. In general, both the farrowing rate and 
litter size are still rather low [276-279]. However, recently this technique has been developed and 
has been producing satisfactory results, indicating a promising solution for this problem [280-
282].  Also, the efficiency of the IVP procedure in producing viable embryos in pigs is still 
considered low compared to using IVP in cattle or mouse  [283]. A successful IVP procedure is 
considered an important component for using embryos in pig breeding, in addition to other 
reproductive techniques [265]. Also, collecting the oocytes for IVM, or embryos from live 
animals by using endoscopic procedures, has been developing more than regular surgical 
methods [284-286]. Although this procedure requires few small incisions for instruments, 
endoscopic procedures still require anesthesia and other surgical precautions [267]. Therefore, 
endoscopic procedures are less applicable for individual farms, but are considered to be 
minimally invasive surgical methods of transferring embryos [284].  
Overall, the ability to use embryos transfer and other reproductive techniques, such as IVP and 
vitrification in the pig industry, can support genetic improvement in pig breeds. Also, using 
different reproductive techniques can enhance the biosecurity of embryos to prevent disease 
transmission. However, the commercial application of embryo transfer faces big challenges in 
the pig industry due to the requirement of surgical procedures for both the collection and 
transference of the embryos. Optimizing reproductive technologies such as non-surgical embryo 
transfer and IVP can play an important role in supporting pig productivity and quality.   The 
ability to make the embryo transfer (ET) more applicable to use by nonsurgical method safely 
and under field condition become the interest of many studies that tried to apply ET 
commercially in pig industry [281]. Recently, non-surgical deep-uterine ET has been developed 
and showed satisfactory results when using fresh embryos in gilt and sows [287]. Using this 
technique was able to reach 40% farrowing rate indicating to the promising way that can be used 
for ET in pig [288]. In addition to ET, preserving pig embryo for the long or short term using 
vitrification technique represent a critical point in term handling the embryos that were used in 
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ET. Vitrified pig embryos techniques have developed rapidly using many deceives [289, 290] 
and showing successfully results in producing live piglets [291]. Having successful tools to 
preserve the pig embryo and nonsurgical transfer represent a critical point in progress for 
international trade of pig embryos that can be used for the swine industry. This could lead to 
convincing pig breeding companies to support research in IVP or embryo transfer to maximize 
efficiency. These techniques (embryo preservation) can allow us to protect different pig breeds 
that play an important role in meat production from future extinction, as well as ensuring global 
food safety. 
  
1.9 Genes transcription regulation in oocytes 
The transcription factors and proteins stored in the cytoplasm have an essential role in oocyte 
maturation and early embryogenesis [292]. During the growing phase of oocytes,  transcription is 
very active, and oocytes accumulate a large amount of mRNA and protein for oocyte maturation 
and early embryo devlopment [293, 294]. The accumulation of maternal mRNA is required for 
proper development of the zygote [193]. This transcription and storage of mRNA becomes silent 
as oocytes transform from the GV to GVBD stage [295].  After transcriptional silencing 
(regulated by epigenetic mechanisms), oocytes depends on stored transcripts to resume the 
meiosis and early cleavage division after fertilization [296, 297]. After meiosis resumption, the 
gene expression in the oocyte is regulated by cytoplasmic polyadenylation. In general, 
polyadenylation elongates poly (A) tails of some classes of existing mRNA, leading to increased 
translation and protein level. Deletion of poly (A) tails (deadenylation) is associated with mRNA 
degradation [298]. Thus, regulation of poly (A) tail length is a key mechanism that regulates the 
activity of maternal mRNA. Cytoplasmic polyadenylation involves in meiotic maturation of the 
oocyte in both mouse and Xenopus via the translational activation of the mRNAs encoding 
regulators of meiotic maturation [298]. In bovine, studies on oocytes and embryo indicated that 
polyadenylation of different mRNA is involved in the meiotic resumption and first embryonic 
cleavage [299]. It was found that the pattern of polyadenylation can change between the high-
quality embryo and low. Also, abnormal polyadenylation can impede the embryo development.  
During oocyte maturation, the quantity of protein synthesis changes due to either deadenylation 
or degradation of mRNA [296]. This phenomenon may explain the differences in the global 
mRNA transcripts in oocytes between GV and MII stage [295]. In human, gene expression (20 
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genes) was followed over  the maturation period of oocytes at different meiotic stages (GV, MI 
and MII) and the results showed that gene expression  varies between  the nuclear maturation 
stages [300]. In bovine, a study evaluated the differences in gene expression between GV vs MII 
from the adult and pre-pubertal derived oocytes during IVM [301]. It was observed that 695 and 
553 genes were differentially expressed in oocytes between GV vs MII stage in the adult and 
prepubertal groups respectively. Also, same study found that genes were differentially expressed 
in oocytes between prepubertal vs. adult bovine in GV (333 genes) or MII (549 genes) stages 
[301]. It is suggested that the gene expression changed over maturation due to the selective 
deadenylation of maternal mRNA transcripts [42]. The age of a donor for oocytes can also affect 
gene expression. A study on oocytes derived from pre-pubertal pigs found 59% of differentially 
expressed genes (587/999 genes) had decreased transcript abundance compared to oocytes 
derived from cyclic females [302]. While the other 41% of differentially expressed genes (412 
out of 999) displayed an increase in oocytes derived from pre-pubertal compared with cyclic 
females. The gene expression of oocyte can be affected with different conditions including 
oocyte development stage, microenvironment of oocyte and age of donor. 
 
1.10 Vitrification of pig embryo  
Embryo cryopreservation has become an important tool to store porcine genetic material for a 
long-term period. Many benefits can be gained from this process, including the storage of high–
value pigs, protection of genes from disease outbreaks, and reduction in the cost of transport of 
genetic material. Vitrification is one cryopreservation method that has been applied to oocytes 
and embryos of various mammalian species [303] including the pig embryo. Vitrification is a 
process that depends on the solidification of a solution containing a high concentration (4-6 M) 
of the cryoprotective agent (CPA) inside the cell during rapid cooling. The most common 
cryoprotectants (CPA) that have been used are ethylene glycol alone or ethylene glycol 
combined with dimethyl sulfoxide (DMSO) [142]. During the cooling process, cellular fluid 
converts to a glass-like amorphous state and all cellular motions and biological activities are in a 
holding pattern [304, 305]. Vitrification minimizes ice crystal formation by passing through 
critical temperatures very rapidly. However, the utilization of CPA at a high concentration may 
cause injuries due to cytotoxicity [306]. Successful vitrification depends on two factors: a very 
high concentration of CPA and a rapid cooling and warming rate (2000-20000 ºC/min). This 
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technique has been used to successfully vitrify mice embryo without the formation of 
intracellular ice [305].  
Historically, cryopreservation of pig embryos has been challenging due to the high quantity of 
internal lipid vesicles, which cause chemical or physical damages [307]. Vitrification method 
overcomes this issue of membrane injuries caused by chilling. As such, it has become the 
method of choice for the preservation of pig embryos [308]. The first successful piglets born 
from vitrified embryos were obtained from in vivo-derived blastocysts [307, 309]. Over the last 
25 years, several vitrification protocols were developed for pig embryos [310, 311]. The 
differences among these protocols are related to two main points: the vitrification carrier and the 
cryoprotectants. Vitrification carriers are designed to increase the speed of the cooling/warming 
rate [312]. It requires a smaller volume of CPA, which increase the cooling rate and improve the 
heat transfer [313]. Vitrification carriers (cryotop and cryoloop) are opened system that could 
carry <1 µl of CPA and could allow a direct contact with liquid nitrogen (LN2) to increase the 
cooling rate (20000 ºC/min) [313]. Another type of vitrification carrier is a closed system, which 
is designed to do not have direct contact of the embryo with LN2. This system was also used to 
vitrify pig embryos derived from in vitro [314] and in vivo [311] methods.  
Pig embryos derived from IVP are the most likely to survive after vitrification when they are at 
morula or at a blastocyst stage compare to embryos at a 2-4 cell stage [315]. It is possible that 
high lipid content at an early embryonic stage decreases as an embryo develops [316]. Therefore, 
many studies have suggested chemically or physically removing lipid content (delipation) from 
embryos could improve survival rate after vitrification [317, 318]. One study developed a 
mechanical delipation protocol by using centrifugation that removed the intracellular lipid from 
the embryo within the intact zona pellucida [298]. Chemical delipation also could be applied by 
using phenazine ethosulfate, which reduced the lipid content in the IVP embryo [319].  
Culture conditions for an embryo have a role not only in embryo production, but also in 
cryosurvival for an embryo. Nutrients supplemented in culture media such as serum(SR) [320] or 
β-mercaptoethanol(β-M) [321] support the success of vitrification of IVP blastocysts by 
increasing blastocysts survival rate (SR vs Control, 76 vs 67%; β-M vs control, 21.3 vs 18.7%). 
Another study found that adding l-ascorbic acid into the culture and vitrification media enhances 
pig blastocyst survival rate by around 10% [321]. Moreover, vitamins in culture media improved 
the survival rate of the IVP blastocyst by using MEM (Minimum Essential Medium) [322]. In 
 29 
 
summary, the vitrification is a cryopreservation method for pig embryos that has been used as a 
successful tool for a long term storage with minimum cryodamage. Vitrification has an important 
value in pig industry by using vitrified embryo in improving and protecting pig breeds, embryo 
transfer, and reducing the cost of importing and exporting valuable breeds without worry of 
using the live animals. However, the success of vitrification depends on different factors, such 
as, age of embryo donors, vitrification protocol, and developmental stage of embryos. 
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CHAPTER 2 
 
2.0 GENERAL OBJECTIVE AND HYPOTHESIS 
The general objective of this research was to determine the effect of delay meiotic resumption 
strategy of pig oocytes during in vitro maturation on improving the competence of cytoplasmic 
maturation to enhance the efficiency of in vitro embryo production in pigs to be effectively 
vitrified using close carrier system.  
The general hypothesis is that delaying meiotic resumption during the in vitro maturation will 
improve the fertilization, cleavage and blastocyst rates under an in vitro environment and pig 
embryo that derived from in vitro condition will vitrify successfully using close carrier.  
2.1 Specific objectives and hypothesis: 
 
2.1.1 Study 1:  
EFFECT OF DELAY IN MEIOTIC RESUMPTION USING DIFFERENT SUBSTANCES 
ON NUCLEAR MATURATION OF PORCINE OOCYTES AND EMBRYO 
DEVELOPMENT 
 
2.1.1.1 Experiment 1: 
Specific Objective: Evaluate the effect of NPPC, cAMP, cGMP, NO, estradiol, progesterone, 
or testosterone on nuclear maturation of oocytes during IVM. 
Specific Hypothesis: Using NPPC, dbcAMP, cGMP, NO, estradiol, progesterone, or 
testosterone during IVM will inhibit the nuclear maturation progress.   
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2.1.1.2 Experiment 2: 
Specific Objective: Develop a strategy to increase the efficiency of IVM by using one or 
combination of NPPC, cAMP, NO, estradiol, and progesterone in IVM media to delay meiotic 
resumption of pig oocytes. 
Specific Hypothesis: Delaying meiotic resumption of pig oocytes during IVM of pig oocytes 
will improves the fertilization rate and blastocyst production.  
2.1.2 Study 2:  
EFFECT OF DELAYING RESUMPTION OF NUCLEAR MATURATION ON GENE 
EXPRESSION in PORCINE OOCYTES MATURED IN VITRO  
Specific Objective: Determine the influence of delaying meiotic resumption protocol for 
IVM on gene expression of porcine oocytes compared to standard procedures.  
Specific Hypothesis: Different treatments dbcAMP, NPPC+estradiol  and 
dbcAMP+NPPC+estradiol delaying meiotic resumption have different effects on different 
molecular (signaling) pathways and gene expression of matured oocytes. 
2.1.3 Study 3:  
COMPARISON BETWEEN A CLOSED AND OPEN DEVICES TO VITRIFY IN VITRO 
PRODUCED PIG EMBRYOS  
 
Specific Objective: Evaluate the efficiency of pig morulas to survive after vitrification under 
two vitrification systems.  
Specific Hypothesis: In vitro produced embryos would survive the vitrification procedures at 
an equivalent rate using a closed (French Straws (FS)) or an open device (Open Pull Straw 
(OPS)). 
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EFFECT OF DELAYING MEIOTIC RESUMPTION  ON NUCLEAR MATURATION 
OF PORCINE OOCYTES AND EMBRYO DEVELOPMENT 
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Relationship of this study to the dissertation 
In chapter 3, we evaluated the effect of delaying meiotic resumption temporally during IVM on 
nuclear maturation and embryo development by using different substances (NPPC, cAMP, 
cGMP, NO, estradiol, progesterone, and testosterone). In chapter 3, we tried to find the best 
substance or a combination of substances for delaying meiotic resumption, which can improve 
embryo development and can be used in next study (Chapter 4). We tested two hypotheses that 
they are: 1- some follicular substances (NPPC, cAMP, cGMP, NO, estradiol, progesterone, and 
testosterone) can inhibit the nuclear maturation at different levels during IVM; and 2- Delaying 
the nuclear maturation during IVM of pig oocytes improves the fertilization rate and blastocyst 
production. 
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3.1 Abstract 
Insufficient cytoplasmic maturation and unsynchronized nuclear maturation during the in vitro 
maturation (IVM) of porcine oocytes reduce their competence to sustain fertilization and embryo 
development. Delaying nuclear maturation by using natriuretic peptide precursor type C (NPPC), 
cyclic guanosine monophosphate (cGMP), cyclic adenosine 3, 5 monophosphate (cAMP), nitric 
oxide (NO), and hormones (testosterone, progesterone and estradiol) could enhance oocyte 
competence. The goal of this study was to evaluate the effects of these different substances to 
inhibit nuclear maturation during IVM without affecting the ability of the oocyte to sustain 
embryo development. Cumulus-oocyte complexes (COCs) were collected from ovaries of 
slaughtered prepubertal gilts. In the first experiment, different follicular substances (NPPC, 
cAMP, cGMP, NO, testosterone, progesterone and estradiol) were added to maturation media to 
evaluate their effects on nuclear maturation of oocytes during IVM. In the second experiment, 
the usage of these follicular substances was optimized. The effect of these follicular substances 
on nuclear maturation of oocytes was evaluated at different times (2, 6, 18, and 22 hrs) during 
IVM. The COCs were incubated for 22 hrs in maturation medium without LH and containing the 
optimized follicular substance. After this incubation, COCs were transferred into a maturation 
medium containing FSH and LH for another 22 hrs. Nuclear maturation was evaluated after 
these two periods of incubation. The results indicated that cAMP (CA, 1mM), the mix of NPPC 
(1000 nM) and estradiol (100 ng/ml, NE), and the combination of previous treatments (CANE) 
delayed the meiotic resumption for 22 hrs without effecting the viability of the oocyte. In the last 
experiment, delaying meiotic resumption with CA, NE, or CANE treatments were applied into 
the IVP to evaluate the ability of the treated oocyte to sustain embryo development. At day 7 of 
the culture period, the blastocyst rate did not show any significant differences among the 
treatments compared to the control (Pff). In conclusion, using NPPC plus estradiol and cAMP 
and their combination can be considered a promising way to delay the nuclear maturation 
without having any effects on the final nuclear maturation (MII) of oocytes, and sustain embryo 
development. 
 
3.2 Introduction 
In vitro embryo production, (IVP) is an important technique in improving the genetics of a herd, 
controlling disease outbreaks, and for long-term preservation of the genetics resource of a breed 
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[5, 323]. However, IVP in pig still faces many obstacles during in vitro maturation (IVM), in 
vitro fertilization and in vitro culture. During IVM, oocytes need to complete two important 
processes: nuclear and cytoplasmic maturation. The completion of these processes ensures that 
the oocytes will be competent for fertilization and embryo development [27]. One of the most 
common problems to overcome is insufficient cytoplasmic maturation of oocytes during in vitro 
maturation. This problem is identified as the primary reason for low competence of in vitro 
matured oocytes, leading to abnormal development of the embryo after fertilization [6, 324].  
Poor cytoplasmic maturation is a result of insufficient time for the cytoplasm to acquire factors 
involved in an important process of IVP. This problem is amplified by the variability of the 
maturation status of COCs derived from different sizes of follicles [24, 325]. Oocytes 
spontaneously resume meiotic resumption in in vitro conditions. It is expected that oocytes 
collected from ovaries have different nuclear maturation stages and will reach metaphase II at 
different times, leading to variation in cytoplasmic maturation [324]. Because RNA synthesis 
and the accumulation of many other important factors are essential for cytoplasmic maturation, 
timing is a critical issue for oocytes in terms of developmental competence. After oocytes start 
meiotic resumption , important factors provided by cumulus cells decrease significantly due to 
the fact that their gap junctions with the oocyte are removed [218]. During  oocytes 
transformation from the GV to GVBD stages, the transcription of mRNA becomes silent [295]. 
Therefore, the factors that are produced from oocytes participating  in oocyte competence and 
oocyte –cumulus cell communication will be dropped. So, it could be hypothesized that delaying 
meiotic resumption may give more time for the oocyte to accumulate the important factors 
required to sustaining embryo development by maintaining gap junction communications 
between oocyte and cumulus cells. 
Meiotic arrest in the oocyte is controlled by the level of cyclic adenosine 3, 5 monophosphate 
(cAMP) that increases due to signals from follicular cells [73]. Degradation of cAMP is 
prevented via the inhibition of type 3 phosphodiesterase in the oocyte by cyclic guanosine 
monophosphate (cGMP) produced in cumulus cells [82, 326]. Also, cGMP has a direct effect on 
gap junction communication (GJC). It has been observed that cGMP inhibits luteinizing 
hormone-induced disruption of GJC in rat granulosa cells [117]. Thus, cGMP plays a critical role 
in meiotic arrest by maintaining GJC between oocytes and cumulus cells, which maintain a high 
level of cAMP in oocytes. Recently, several studies have indicated an important role of the 
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natriuretic peptide precursor type C (NPPC) in the meiotic arrest of oocytes of bovine [235], 
mice [327] and pig [328]. NPPC is produced from mural granulosa cells [97], and natriuretic 
peptide type 2 (NPR2) receptors are present in cumulus cells [328]. The primary role of NPPC is 
to stimulate cGMP production in cumulus cells, inhibiting the type 3 phosphodiesterase [69]. 
Nitric oxide (NO) is also involved in meiotic arrest. In the follicle, endothelial NO synthase 
(eNOS) of  mural cells produces the NO [329], which increases cGMP production from cumulus 
cells [127]. Meiotic arrest could also be control by steroids. Estradiol and testosterone were 
found to increase the expression of NPR2 in vitro [100]. A high level of testosterone inhibited 
meiotic resumption  in mouse oocytes [138] and support cGMP production [100]. In addition, 
progesterone was reported to have an inhibitory effect on cAMP phosphodiesterase (PDE) 
activity, which cause a cAMP degradation in oocytes and lead to an increase of cAMP 
concentration in oocytes [330]. The goal of this study was to evaluate the effect of follicular 
substances (NPPC, cAMP, cGMP, NO, estradiol, progesterone, and testosterone) on nuclear 
maturation of oocytes during IVM and establish a strategy to delay the nuclear maturation to 
improve the ability of the oocyte to sustain embryo development. 
 
3.3 Material and methods  
3.3.1 Media preparation: 
All chemicals were purchased from the Sigma Chemical Co, Oakville, Canada. Any chemical 
that was not from Sigma is noted. All media prepared during the study were filtered with a 0.22 
μm filter (Argos technology, Elgin, USA). 
 
3.3.2 Oocyte collection and in vitro maturation (IVM): 
Ovaries were collected from prepubertal gilts at a local slaughterhouse and transported to the 
laboratory within two hours. Ovaries were dissected from adjacent tissues and rinsed three times 
in saline at room temperature (0.9% NaCl). Cumulus-oocyte complexes (COCs) were aspirated 
from follicles that were 3-6 mm in diameter. The COCs were evaluated under stereo microscope 
to select grade 1 and 2 and transferred into TCM-199 (Invitrogen, Burlington, Canada) 
supplement with HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, 25 mM)) and 
antibiotic-antimycotic (1X). After washing three times using this solution, COCs were 
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transferred into maturation media (TCM-199 (Invitrogen), 0.1% polyvinyl alcohol , 3.05 mM D-
glucose , 0.91 mM sodium pyruvate , antibiotic-antimycotic 1X (Invitrogen), 10 ng/ml EGF, 
0.57 mM L-cysteine , 0.01 U/ml Folltropin® (Bioniche, Oakville, Canada)) supplemented with 
one of the tested substances (treatments). A maximum of 50 COCs per well were used for in 
vitro maturation. Selected oocytes were incubated for 40-44 hrs under 5% CO2, 5% O2 and 90% 
N2 in a humidified environment at 38.5°C.  
 
3.3.3 In Vitro Fertilization (IVF) and Embryo Culture (IVC): 
By the end of the maturation period, oocytes were denuded with 0.1% hyaluronidase in medium-
199. Denuded oocytes were washed three times in a modified tris-buffered medium (mTBM) 
[22]. This media was supplemented with 1 mM caffeine and 0.4% bovine serum albumin (BSA; 
Minitube,Verona, USA). Washed oocytes were transferred into mTBM that was used as a 
fertilization medium at a concentration of 50 oocytes/500 µl . For semen preparation, semen 
straws were thawed at 50°C for 10 seconds and centrifuged with mTBM media twice at 1000 g 
for 7 min twice. The concentration of sperm added to the oocytes was 0.1×10
6
 sperm/ml. The 
incubation with sperm continued for 6 hours at 38°C in an environment of 5% CO2, 5% O2 and 
90% N2. After 6 hrs of incubation, the presumptive zygotes were washed and cultured in NCSU-
23 [23] supplemented with 0.4% BSA for 48 hrs. The culture media was modified by replacing 
glucose with sodium pyruvate (0.33 mM) and sodium lactate (4.5 mM). Subsequently, embryos 
were transferred into a non-modified culture media (NCSU- 23, with glucose) for another 7 days. 
The zygotes were incubated in 5% CO2, 5% O2 and 90% N2 in a humidified environment at 
38°C. 
 
3.3.4 Assessment of oocyte nuclear maturation:  
At the end of the maturation period, COCs were mechanically denuded from cumulus cells by 
repeated pipetting. They were fixed in 4% paraformaldehyde. Theses oocytes were incubated for 
30 min in 0.5% Triton-X 100 in DPBS at room temperature for membrane permeabilization. 
After the incubation, the cells were washed three times in DPBS+0.1% PVA buffer. Then, they 
were transferred into 0.05% Tween-20 in DPBS for 30 min at room temperature for re- 
membrane permeabilization. After this incubation, oocytes were washed three times in DPBS + 
0.1% PVA. Then, oocytes were stained using an anti-lamin A/C and 4′,6-diamidino-2-
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phenylindole [DAPI] technique [331]. After staining, the oocytes (N for each group ≥ 75 
oocytes) were examined with an epifluorescence microscope and classified based on the nuclear 
status: germinal vesicle (GV), germinal vesicle breakdown (GVBD), metaphase I (MI), or 
metaphase II (MII) (Fig. 3.1-A).  
 
Fig.3.1 Different nuclear maturation stages (GV and MII) in pig oocyte and the viability of oocyte. A) 
DAPI and LAMIN staining of oocytes: Germinal vesicle (GV) and metaphase II (MII). B and C) 
Propidium iodide (PI) viability assessment of oocytes by staining the nucleus of oocyte in red  
(C )(Magnification 400X).   
 
3.3.5 Evaluation of oocyte viability 
The viability assessment of oocytes was done based on oolema integrity by using a propidium 
iodide (PI, Invitrogen) stain. The denuded oocytes were washed in washing buffer (BPS 
X1+PVA 1%) three times. The staining solution was prepared by adding 12 µM of PI in washing 
buffer.  After the incubation, oocytes were transferred to a staining solution and incubated for 7 
min at 37
o
C in a dark area. The oocytes were then washed three times in the washing buffer. 
Stained oocytes were observed by fluorescence microscopy (400X). The dead oocytes stained in 
red florescence due to disruption of cellular membrane (Fig. 3.1-C), while viable cells were not 
stained (Fig.3.1-B). The proportions of viable oocytes cultured in different treatments are 
presented as mean ±SEM (Fig. 3.3).  
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3.3.6 Evaluation of cumulus expansion: 
Cumulus expansion was  assessed at the end of IVM using the subjective scoring method based 
on degree of expansion described by Tao et. al. [118] with modifications. Cumulus expansion 
was classified into four categories: no expansion (0, the cumulus cells (CC) are compact around 
oocytes), minimum response (1, slight expansion of cumulus cells), medium response (2, all 
outlayers of CC are expanded except for the CC layers around the oocyte), complete expansion  
(3, all cumulus layers are expanded).  The cumulus expansion was scored as one value according 
to the majority ( ≥70%), since most cumulus-enclosed oocytes in a well had the same level of 
expansion [118, 332-334].  
 
3.3.7 Experimental Design 
3.3.7.1 Experiment 1: Effect of different follicular substances on nuclear maturation of 
porcine oocytes  
The first experiment was undertaken to evaluate the dose response of various substances on 
oocyte nuclear maturation and cumulus expansion (assessed at the end of IVM). Oocytes were 
submitted to: 
1- NPPC at a concentration of 100, 250, 500, or 1000 nM. 
2- NO donor (S-nitroso-N-acetyl-DL-penicillamine) at a concentration of 0.5, 0.75, 1, 5, or 
10 mM. 
3- Dibutyryladenosine 3': 5' cyclic monophosphate (dbcAMP) at a concentration of 0.5, 1, 
or 2 mM.  
4- cGMP at a concentration of 2, 5, or 10 µM. 
5- Testosterone at concentrations of 500, 750, or 1000 ng/ml 
6- Estradiol at a concentration of 100 ng/ml 
7- progesterone at a concentration of 100 ng/ml 
NPPC, dbcAMP, NO, and cGMP were prepared by dissolving in TCM 199 and storing at -20°C 
until used. The steroid hormones (testosterone, estradiol and progesterone) were dissolved in 
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100% ethanol, and then stored at 4°C. The doses of progesterone and estradiol (100 ng/ml) were 
selected based on the previous study done in our lab to evaluate their effects on nuclear 
maturation [335]. All the substances were added to the maturation media from the beginning of 
the IVM period to the end. At the end of IVM, cumulus expansion and viability rate were 
evaluated, and oocytes were stained to assess the nuclear maturation stages.  
 
3.3.7.2 Experiment 2: Evaluate the effect of delaying meiotic resumption at different times of 
IVM on nuclear maturation, and embryo development 
The aim of experiment 2.1 was to evaluate the ability of selected folliclular substances at an 
optimal concentration to delay meiotic resumption at certain times (2, 6, 18, 22 and 44 hrs) 
during IVM. NPPC (1000 nM), dbcAMP (1 mM), NO (1 mM), estradiol and progesterone (100 
ng/ml) were used alone or as a combination during the first 22 hrs of IVM in a maturation media 
(without LH). A portion of oocytes after a predetermined time of incubation (2, 6, 18 and 22 hrs) 
were fixed and stained to assess the nuclear maturation stage. After the incubation with the 
follicular substance, the remaining oocytes were washed and transferred into a regular 
maturation media (with LH). In vitro maturation of oocytes continued until the total time reached 
44 hrs. At the end of the maturation period, a group of oocytes (n=25/ replicate) was stained to 
evaluate the nuclear maturation stage.  
The second experiment (2.2) was performed to evaluate the effect of the selected substances on 
in vitro fertilization and embryo development. Three treatments groups were designed based on 
the functions during folliculogenesis: dbcAMP, NPPC+estradiol, or NPPC+estradiol +dbcAMP. 
These substances were added to maturation media (without LH) for the first 22 hrs of IVM. 
Then, oocytes were transferred to maturation media (with LH) for another 22 hrs. The control 
group used was 10% Pff in a maturation media for 44 hrs. By the end of the maturation period, 
oocytes were used for IVF and IVC to evaluate the effect of delaying meiotic resumption on the 
cleavage and blastocyst rate. The quality of embryos (blastocyst) were evaluated based on the Bo 
and Mapletoft [336]. Briefly, grade 1 (G1) denotes good quality embryos that have symmetrical 
and spherical mass with individual blastomeres, viable embryonic mass, and less than 15% of 
irregular cellular materials. The embryo has a central cavity, big size, and thin zona pellucida. In 
grade 2, the embryos have moderate irregularities in the overall shape of the embryonic mass and 
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50% of the embryonic mass should be in intact. While grade 3 embryos represent the poor 
quality that has main irregularities in the shape of the embryonic mass or in size, color, and 
density of individual cells. There is a small cavity and at least 25% of embryo mass must be 
intact. The data of embryo in grade 3 were not considered in this study due to their low quality.    
 
3.3.8 Statistical Analysis 
Statistical analysis was done using SAS 9.2 (SAS Institute Inc., Cary, NC, USA). Each 
experiment was replicated 3-5 times. All data are presented as mean ± SEM.  In experiment 1, 
the differences between treatments in each nuclear maturation stage and viability rate were 
analyzed by one-way ANOVA. For experiment 2, the proportion of oocytes in each maturation 
stage, and embryonic cleavage (Day 2) and blastocyst rates (Day 7) were analyzed by one-way 
ANOVA. All the analysis were followed by Fisher's least significant difference (LSD) test and a 
P-value ≤ 0.05 was used to consider different between treatments.  
3.4 Results 
3.4.1 Experiment 1: The inhibitory effect of different substances on nuclear maturation of 
porcine oocytes  
3.4.1.1 Inhibition of nuclear maturation  
At a concentration of 1000 nM, NPPC significantly increased (P<0.001) the rate of oocytes in 
GV stage compared to other concentrations and control (Pff) (Fig 3.2-A). Also, treatment with 
dbcAMP in a concentration of 1 or 2 mM resulted in a higher proportion rate (P < 0.001) of 
oocytes in the GV stage compared to other treatment (0.5 mM) or control. In addition, the 1 and 
2 mM of dbcAMP inhibited significantly the rate of oocytes to reach MII stage compared to 
control or 0.5 mM treatment. With NO treatment, the concentration of 1mM significantly (P < 
0.001) inhibited the nuclear resumption by increasing oocyte in GV stage compared with other 
concentrations and control. It was also observed that the different NO concentrations result in 
significant reduction in oocytes in MII stage (P < 0.001) compared to control. Although all of the 
cGMP treatments (Fig. 3.2-D) showed a higher rate of the oocytes in GV stage (P = 0.03) 
compared to control, the rate of oocytes in the GV stage was less than 20% for every 
concentration. With steroid treatments (testosterone, progesterone, and estradiol), there was no 
significant different between treatments and control in all concentrations (Fig. 3.2- E, F). 
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However, it was observed that the level of oocytes in MII dropped significantly in all hormones 
treatments compared to control. 
 
3.4.1.2 Viability rate and cumulus expansion  
There were no differences in the viability rate of oocytes treated with cAMP, cGMP, 
testosterone, estradiol and progesterone compared to control or among the tested concentrations 
within the same treatment. With NO treatments, high concentrations (5, 10 mM) decreased the 
viability rate significantly (P < 0.001) while the viability rate with low NO concentration (0.5-1 
mM, Fig.3.3-B) did not differed (P = 0.05) compared to control. In NPPC treatments, the Pff 
group and 0.5 nM NPPC had a higher viability rate (P < 0.001, Fig 3.3-A) of oocytes compared 
to other NPPC concentrations. The cumulus expansion degree of COCs was numerically 
decreased with all treatments compared to control (Pff). The degree of cumulus expansion in 
high concentrations of NPPC (1000 nM), cAMP (1, 2 mM) was lower compared with other 
treatment concentrations and control. The NO treatment recorded the lowest cumulus expansion 
degree compared to control.   
 
 
 
 
 
 
 
 
 
 
  
 
 
4
2
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Fig. 3.2 Effect of NPPC, NO, cAMP, cGMP, testosterone, estradiol, and progesterone on nuclear 
maturation rate of oocytes (means ± SEM) after 44 hrs of maturation. Immature oocytes (germinal vesicle 
and germinal vesicle breakdown) were compared with mature oocytes (metaphase I and II) to highlight 
the dose effect of  these substances on the nuclear maturation progress. Value with different superscripts 
for same stage of nuclear maturation is significantly different at P ≤ 0.05. NPPC= Natriuretic peptide type 
C, NO= Nitric oxide, cAMP= Cyclic adenosine monophosphate, cGMP= Cyclic 
guanosinemonophosphate. Pff = Porcine follicular fluid. 
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Fig. 3.3 Effect of different doses of NPPC, NO, cAMP, cGMP, testosterone, estradiol, progesterone on 
the viability rate (means ± SEM) and cumulus expansion degree (white number inside the box) of 
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matured oocytes. Values with different superscripts within a substance are significantly different at P ≤ 
0.05. Cumulus expansion degree was scored as one value according to the majority since most cumulus-
enclosed oocytes in a well had the same level of expansion 
 
3.4.2 Experiment 2: Evaluate effect of delaying meiotic resumption on nuclear maturation at 
different times during IVM of porcine oocytes  
 
3.4.2.1 Delaying meiotic resumption 
The results of Pff and maturation media group (no treatments) showed that the proportion of  
oocytes in the GV stage dropped significantly (P = 0.01) at 18 and 22 hrs of IVM respectively. 
The rate of oocytes in MII stage for Pff and maturation media at 44 hrs was 64.1% and 44.2 %, 
respectively. In addition, all substances that showed an inhibitory effect on meiotic resumption 
were used as a combination in maturation media (NPPC,1000 nM; cAMP,1 mM; NO,1 mM; 
estradiol and progesterone; 100 ng/ml) to evaluate the maximum inhibition effect on meiotic 
resumption. By the end of IVM (44 hrs), incubation of COCs with this combination for 6, 18, 
and 22 hrs (without LH ) resulted in 54.1%, 75.9% and 72.9% matured oocytes at GV stage, 
respectively. In comparison, when NO was removed from this combination, the number of 
oocytes at the GV stage dropped to less than 15% (appendix, 8.2). These results indicated that 
NO prevented the oocytes from reversing to meiotic resumption.  
For this reason, the combination (without NO) were evaluated at 2, 6, 18 or 22 hrs. The results 
(Fig.3.4-B) showed that over 80% of the oocytes were arrested at GV stage in the first 22 hrs of 
IVM. The proportion of oocytes in MII by the end of IVM using the mix without NO was 
approximately 50% for the 22 hrs treatment group compared 60% with the control (Pff). Then, 
the substances were evaluated individually over IVM. The results of using estradiol, 
progesterone, NPPC and NPPC+ progesterone showed a decrease in oocytes in the GV stage 
over the first 22 hrs of IVM (Fig. 3.4). However, a combination of NPPC+estradiol arrested 
oocytes at the GV stage (>80%) for 22 hrs of IVM (Fig. 3.4-D). After removing these 
substances, the MII rate for this treatment at 44 hrs was 62.61% and it was not significantly 
different from Pff group (Fig. 3.5-A). 
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3.4.2.2 Effect of delaying meiotic resumption on embryo development  
Based on the results of the previous study (section 3.4.2.1), we found that NPPC + E, cAMP and 
the combination of NPPC, E, and cAMP prevented the meiotic resumption over 22 hrs 
effectively with more than 80% of oocytes in the GV stage. In addition, these treatments did not 
affect the final nuclear maturation rate of treated oocytes (MII) compared to control (Pff). 
Therefore, these treatments (NPPC +E, cAMP and combination of NPPC +E+cAMP) were 
selected for IVF-IVC procedure. This experiment (2.2) evaluated the effect of delaying meiotic 
resumption on embryo development. The Pff treatment was used as a control for the IVM 
procedure. The results of cleavage and blastocyst rates (Table 3.1) did not show any differences 
between treatments groups and the control. 
 
  
 
4
7
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Fig. 3.4 Effect of different substances alone or in combination on nuclear maturation of porcine oocytes. 
The mix was added to maturation media (without LH) at the beginning of IVM. After pre-determined 
times (2, 6, 18, 22 hrs) the oocytes were fixed. After a 22 hr of maturation, a group of oocytes was 
transferred to regular maturation media (with LH) to complete the maturation process. By 44 hrs, the 
oocytes were fixed for staining to evaluate the proportion of MII. NPPC= Natriuretic peptide type C, NO= 
Nitric oxide, cAMP= Cyclic adenosine monophosphate, Pff= Porcine follicular fluid, GV = Germinal 
vesicle, MII= Metaphase II. Values with different superscripts for the same stage of nuclear maturation are 
significantly different at P ≤ 0.05. 
 
 
 
 
Fig. 3.5 Effect of delaying meiotic resumption in pig oocytes using NPPC+ estradiol (E) treatment for 22 
hrs on final nuclear maturation stage (MII) and oocytes viability. A) The metaphase II rate of matured 
oocytes in NPPC+ estradiol  treatments compare to Pff group by the end of IVM (44 hrs).  B) The 
viability rate of matured oocytes in NPPC+ E treatments at different times during IVM. There are no 
statistical differences among the treatments in different parameters.  
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Table 3.1: Ability to sustain embryo development on oocytes treated with different meiotic inhibitory 
substances, NPPC= Natriuretic peptide type C, E= Estradiol, cAMP= Cyclic adenosine monophosphate, 
CANE =Natriuretic peptide type C+ E+ cAMP,  Pff= Porcine follicular fluid. There are no statistical 
differences among the treatments in different parameters.  
 
3.5 Discussion  
Recent studies have highlighted the role of NPPC/NPR2 or nitric oxide-cGMP pathways in 
meiotic arrest [69, 97, 117, 328, 337]. Many elements of these pathways have been identified 
such as cGMP, cAMP, estradiol, and testosterone [69, 100]. In this study, we evaluated the 
inhibitory effect of using NPPC, cAMP, cGMP, NO, estradiol, testosterone, and progesterone on 
nuclear maturation. The results of experiment 1 (Fig. 3.2) showed that 1000 nM NPPC increased 
the inhibitory effect on oocytes compared to other concentrations. Another study [328] found that 
1000 nM of NPPC inhibited meiotic resumption  in porcine oocytes compared to untreated. The 
inhibitory effect of NPPC on meiotic resumption  was also confirmed in the mouse [97], bovine 
[338], and goat [339].  
The cGMP messenger is the key to regulate the level of cAMP, inhibiting phosphodiesterase 3A 
enzyme in oocytes [82]. The cGMP is known to diffuse through the plasma membrane to increase 
its level in cells [132]. cGMP analogs have been used to inhibit meiotic resumption in mouse 
[98], and rat [340]. In this study, any tested concentrations of cGMP did not prevent meiotic 
resumption (Fig. 3.2-D). A recent study in porcine oocytes found that the ability to inhibit 
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meiotic resumption  by cGMP was lost when FSH was present in the maturation media during the 
IVM process [131]. For this study, we can hypothesize that the level of cGMP used in this study 
could not prevent meiotic resumption due to the essential presence of FSH. Interestingly, a recent 
study found that using a high level of cGMP (5 mM) can inhibit meiotic resumption in presence 
of FSH, while lower concentrations (0.05 and 0.5 mM) could not [132]. For our study, we 
avoided using high concentration due to a potential effect on the viability of oocytes.  
As a high level of cAMP in the oocyte is the key for a meiotic arrest, many studies have used the 
cAMP analog (dbcAMP) in vitro to prevent meiotic resumption [10, 89, 227]. In this study, 
dbcAMP inhibited meiotic resumption at a minimum concentration of 1 mM (Fig. 3.2-B). This 
result concurred with several studies that used dbcAMP as a treatment to delay meiotic 
resumption [10, 14, 227, 341, 342]. This process has been found to improve cytoplasmic 
maturation in oocytes and embryo development [324]. In experiment 1, cumulus expansion of 
oocytes at higher concentrations (1 and 2 mM) of cAMP (Fig. 3.3- C) was lower than at a low 
concentration treatment (0.5 mM) and Pff. These results are in contradictions with the results of 
Vanderhyden [332] who found that treating porcine COCs with increasing dbcAMP 
concentration (0.05 – 2 mM) improved cumulus expansion. In Vanderhyden's study, they used 
mural granulosa cells in addition to COCs during IVM. It was found culturing mural granulosa 
cells in maturation media with gonadotropin (LH or FSH) increase progesterone production from 
these cells over the time [343]. It has been reported that an increase level of progesterone in 
maturation media could stimulates meiotic resumption in pig COCs [344]. Therefore, it is 
possible that cumulus expansion in Vanderhyden's study happened due to an elevation in 
progesterone leading to meiotic resumption.  
Also, we found that using testosterone, progesterone or estradiol did not prevent meiotic 
resumption at any concentrations when used alone. However, estradiol  has been reported that 
plays a role in maintaining oocytes in meiotic arrest [345]. An in vivo study in pigs found that 
estradiol concentration after LH surge rapidly declines from 20 to 1 pg/ml [346], which could 
suggests that estradiol may be important during meiotic arrest. Estradiol can up-regulate gap 
junction communications [347], which maintains transport of  meiotic inhibitory factors (such as 
cAMP and cGMP) from cumulus cells to oocytes. In addition, many reports have been observed 
the positive role of estradiol or progesterone on cytoplasmic maturation and embryo development 
[348-351]. Several studies confirmed that using appropriate additives to IVM media can increase 
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the development competence [352-354] indicating that would be possible to improve the 
development competence during meiotic arrest. Therefore, estradiol and progesterone was also 
selected to use in experiment 2 and evaluated its effect as combination with other substances 
(dbcAMP, NPPC and NO) that show ability to delay nuclear maturation. 
In the second experiment, we tried to determine the best combination of substances selected from 
experiment 1 to optimize the ability to delay the meiotic resumption. The result of our study from 
experiment 2 found the combination of NPPC + estradiol was effective at inhibiting meiotic 
resumption for 22 hrs without affecting the final MII rate (Fig. 3.4-D). The inhibitory effect of 
NPPC on porcine oocytes has already been reported [328]. A study on pig oocytes demonstrated 
that a minimum of 10 µM of NPPC in a FSH-induced maturation medium is enough to inhibit 
meiotic resumption [132]. In our study, NPPC alone was not efficient to fully inhibit meiotic 
resumption and present of estradiol supported NPPC ability to prevent meiotic resumption.  
Estradiol seems to increase the mRNA expression of NPR2 ( NPPC recpters ) in cumulus cells of 
mouse, goat and pig COCs [100, 339, 355]. A study using porcine oocytes found that NPR2 
expression increased significantly when estradiol was used in presence of FSH in maturation 
media compared to use of estradiol or FSH alone [355]. Thus, a maximum expression of NPR2 
could allow NPPC to work efficiently to inhibit meiotic resumption, which could explain the 
optimal results of NPPC and estradiol obtained in our study. It was also observed using 
progesterone as a combination with NPPC and E (NPPC+P; Fig. 3.4-C or NPPC+P+E; data not 
shown) did not prevent meiotic resumption. The possible explanation for this case is progesterone 
down regulate the gap junctional communication [356]. This drop in communication result from 
the reduction of connexion43 mRNA expression in cumulus cells, as caused by progesterone 
receptors[357]. This condition can lead to close of gap junctional communication that induces 
GVBD on porcine oocytes used in our study. In consequence, many components that produce in 
cumulus and have role in inhibiting meiotic resumption such as cGMP will not able to transport 
to oocytes to prevent meiotic resumption.  
As our goal was to find a treatment that delayed the meiotic resumption for maximum tested time 
(22 hrs), three treatments (CA, NE, and CANE) were selected for use in the two-step strategy. 
These treatments did not affect the starting meiotic resumption after they were removed from the 
media and the final nuclear maturation (MII) was equivalent to control. Therefore, these 
treatments were used in the IVF-IVC procedure. We observed that 22 hrs of inhibition with NE, 
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CA, or CANE can result in embryo development rates equivalent to results with Pff. This 
optimized time is longer than what has been reported in mouse [358] and bovine [359, 360]. It 
could suggest that the metabolism activities of the pig oocytes are lower than other species. 
Interestingly, no differences among treatments groups (Table 3.1) in cleavage or blastocyst rate 
were observed. Thus, our different treatment group can offer a basis to develop a defined medium 
without animal products to reduce the variability induced by Pff or enhance biosecurity in the 
production of germplasm. 
In summary, our study indicated that NE, CA, or CANE can effectively inhibit meiotic 
resumption without affecting the viability rate or final maturation rate (MII), which provides a 
promising method to delay meiotic resumption  in a two-step strategy and improve the quality of 
the in vitro produced embryos to level equivalent of using Pff treatment.  
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EFFECT OF DELAYING RESUMPTION OF NUCLEAR MATURATION ON GENE 
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Relationship of this study to the dissertation 
In the previous study (Chapter 3), different substances have shown a high ability to delay meiotic 
resumption successfully, and three treatments were selected: NE, CA, and CANE. These 
treatments showed an equivalent effect to that of Pff on embryo development. This study was 
focused on evaluating how these treatments can affect gene profiles of matured oocytes during 
IVM. The changes in gene expression and pathways could help to understand how the treatments 
can affect oocyte competence positively to improve embryo development, which can reflect 
positively on the development of IVP procedures. Microarray technique was used to evaluate the 
gene profiles.  
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4.1 Abstract  
This study was designed to evaluate the influence of a delayed meiotic resumption on gene 
expressions and molecular pathways of matured oocytes when compared to standard procedures 
of in vitro maturation using porcine follicular fluid (Pff). Based on previous studies, three 
treatments to delay meiotic resumption were tested during the first 22 hrs of IVM of pig oocytes: 
1) Natriuretic peptide precursor C (NPPC 1000nM) plus estradiol (E, 100 ng/ml; NE); 2) 
dbcAMP (1mM; CA) in maturation medium and 3) a combination of previous treatments 
(NPPC+E+dbcAMP; CANE). Obtained from pig prepubertal ovaries, cumulus oocytes 
complexes (COCs) that have ≥2 layers of cumulus cells and homogenous cytoplasm were 
selected and transferred to one of the treatment groups for 22 hrs. After that, COCs were re-
transferred into a maturation medium containing LH for another 22 hrs. In control group, the 
COCs were incubated into a maturation medium containing Pff (10%) for 44 hrs. The total RNA 
of the matured oocytes was extracted, amplified, labeled, and hybridized to the gene expression 
microarray developed for studies with early stage porcine embryos [361] (treatment vs. Pff) using 
dye swap method. A log 2-fold differences in gene expression between a treatment and reference 
control (Pff) was considered statistically different (P < 0.05). EASE program was used to identify 
biological theme of the differentially expressed genes of each group. While DAVID and 
PANTHER programs were used to most significant biological pathways in each treatment group. 
For all these programs, a P value ≤ 0.05 was used to determine the significance for the gene list. 
The number of differentially expressed genes for NE, CA, and CANE compared to the Pff group 
was 122, 55, and 167 respectively. The results of EASE program showed that CA treatment up-
regulated many genes involved in signal transduction (ARHGAP9, RGS5, BRAP, STAT2 and 4), 
chromosome segregation (TTK and RFC3), mitochondrial activity (TIMM9, MRPS30, MRPL3, 
and IDH3B) and oocyte competence (MRPL3 and HSP90AA1). Using Panther program, our 
analysis demonstrated that this treatment up-regulated pathways related to signal transduction 
(JAK/STAT pathway). The CA treatment down regulated interleukin -18 genes. For the NE 
group, some of these genes were related to MAPK pathway (MAX, MAPK9, REL) or the ERK 
pathway. Our EASE analysis revealed that the NE treatment had up-regulated many genes related 
to nucleus metabolism. Our DAVID analysis revealed that the NE treatment down regulated 
genes involved in fatty acid (SCD5), lipid (PLA2G7), and tyrosine (MIF) metabolisms or ATP 
synthesis (ATP5B). The last treatment (CANE) up regulated genes (EASE program) that regulate 
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metabolism (APOA1, APOD, ACO2, CKMT2, DNAH14, and NDUFB7) and growth (IGF1 and 
ID4). Meanwhile, CANE treatment suppressed genes with roles in signal transduction pathways 
(IL6, HBEGF, and TLR7). 
In conclusion, this study demonstrated that delaying meiotic resumption of pig oocytes with one 
of the tested treatment resulted in a unique molecular profile that could lead to a positive embryo 
development after fertilization.   
 
4.2 Introduction  
The efficiency of  in vitro embryo production (IVP) technique in pigs is low compared to the 
efficiency of IVP of embryos in cattle [362]. The main obstacle for IVP efficiency is poor 
cytoplasmic maturation during in vitro maturation (IVM) process, which leads to the production 
of incompetent oocytes for fertilization and embryo development [5]. Early resumption of nuclear 
maturation and removal of the gap junctions do not allow for an appropriate amount of time to 
acquire a proper level of factors to improve the competence of the oocytes [324]. Recently, 
strategies to delay nuclear maturation during in vitro maturation (IVM) demonstrated an 
improvement of oocyte competence for cattle [363], goat [364] and pig [89]. Delaying 
resumption of meiosis increases the period of communication between oocyte and cumulus cells, 
thereby increasing the exchange of many factors supporting cytoplasmic maturation [324]. Many 
substances have been used to delay the resumption of meiosis, including dbcAMP (dibutyryl-
cAMP) and the natriuretic peptide precursor type C (NPPC) [235, 236, 359]. The dbcAMP was 
used during IVM to improve the competence of oocytes and embryo development in pigs and 
cattle [89, 195, 365]. Our research group have recently demonstrated that a combination of NPPC 
plus E (first 22 hrs of IVM period) efficiently delayed meiotic resumption and resulted in embryo 
development rates equivalent to using porcine follicular fluids in IVM (Chapter 3). This suggests 
that a defined medium (laboratory based) can be developed by using different substances to delay 
meiotic resumption to produce pig embryos. Although most of the results of delaying the meiotic 
resumption strategy on oocytes during IVM have been promising [10, 11, 359], no studies have 
yet reported the effect of a delayed meiotic resumption procedure on the gene expressions and 
related molecular pathways in oocytes.  
It was reported that molecular conditions of oocytes or cumulus cells could be affected by adding 
substances to the maturation media [366-368]. For instance, an increase of Pff supplementation in 
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maturation media (from 1 to 10%) resulted in the up-regulation of factors involved in the 
maturation of oocytes such as: matrix molecules, steroidogenesis, and cell cycle regulators [369]. 
These factors resulted to an improvement in the embryo in vitro conditions. Many genes play a 
key role in oocyte competence and understanding the molecular changes associated with the 
maturation of oocytes under the influence of inhibitory factors could allow for the identification 
of new markers associated with oocyte competencies [370-372]. The aim of this study was to 
determine the influence of an optimized protocol for IVM on gene expression in porcine oocytes 
compared to standard procedures. 
 
4.3 Material and methods  
 
4.3.1 Chemicals and Media 
All the chemicals and media were purchased from the Sigma-Aldrich Company (Oakville, 
Canada). Chemicals that were not purchased from Sigma were noted.  
 
4.3.2 Oocytes Collection  
Ovaries were collected from slaughtered prepubertal gilts at a local abattoir and transported to the 
laboratory in a thermos box containing gel-packs warmed to 37°C within two hours. The ovaries 
were then cleaned of  adjacent tissues and rinsed in saline (0.9% NaCl) at room temperature to 
remove blood contamination. The cumulus-oocyte complexes (COCs) were aspirated from the 
follicles (3-6 mm in diameter). The COCs with ≥ 2 layers of cumulus cells and homogenous 
ooplasm were selected and washed three times with TCM-199 (Invitrogen, Burlington, Canada) 
supplement with HEPES (25 mM) and antibiotic-antimycotic (1X) (Invitrogen). 
 
4.3.3 In Vitro Maturation (IVM) 
The maturation media was prepared without LH (TCM-199, 0.1% polyvinyl alcohol, 3.05 mM 
D-glucose, 0.91 mM sodium pyruvate, antibiotics 1X (Invitrogen), 10 ng/ml EGF, 0.57 mM L-
cysteine, 0.01 U/ml Folltropin® (Bioniche, Oakville, Canada) for the first 22 hrs of IVM. During 
this period, one of four treatments was added to maturation media: 1) porcine follicular fluid (Pff, 
10%) as control group; 2) NPPC (1000 nM) plus E (100 ng/ml); 3) dbcAMP (1mM);or 4) a 
combination of the previous two treatments (NPPC+E+cAMP).  After the first 22 hrs of 
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incubation, the COCs were washed and transferred into maturation media with LH (0.01 U/ml, 
Lutropin - V®; Bioniche) without any treatments. Finally, the COCs were transferred to the 
maturation media and incubated for another 22 hrs in a 5% CO2, 5% O2 and 90% N2 in a 
humidified environment at a temperature of 38.5°C. The control group was maintained in the 
presence of Pff for the next 22 hrs (standard IVP procedure). At the end of IVM, the oocytes 
were mechanically denuded of cumulus cells using 0.1% hyaluronidase. The oocytes were then 
washed three times in MgCl2-free phosphate buffered saline (PBS). Immediately after washing, 
the oocytes ( N =70/ replicate) were transferred into a minimal volume of PBS containing a lysis 
buffer obtained from the Arcturus® PicoPure® RNA Isolation Kit (Applied Biosystems, 
Burlington, Canada). Then, samples were plunged in liquid nitrogen and stored at -80°C until 
RNA extraction. In each IVM run, oocytes were divided between all treatments.  
 
4.3.4 RNA extraction and amplification 
Total RNA was extracted (Six biological replicates for each treatment) using the Arcturus
® 
PicoPure
®
 RNA Isolation Kit (Applied Biosystems) according to the manufacturer’s instructions. 
For high-quality total RNA, the purification procedure was included DNase treatment by using 
RNase-Free DNase Set (Qiagen, Bay St, Canada) to remove the DNA from samples. Finally, the 
pure RNA was eluted in 12µl with an elution buffer. For the quality of purified RNA, all sample 
were evaluated by Bioanalyzer 2100 (Agilent Technologies, Santa Clara, USA) by using the 
RNA 6000 Pico LabChip (Agilent Technologies). Only samples that had an RNA integrity 
number (RIN) of more than 6 were selected (accepted samples: Pff =4, NE =3, CANE =4) for 
further amplification and microarray process.  
The RNA amplification was run using the Arcturus® RiboAmp® HS-PLUS RNA Amplification 
Kit (Applied Biosystems). This procedure consisted of two rounds of amplification according to 
the manufacturer’s protocol. For the linear amplification process, three nanograms of purified 
RNA were used in a 6 hrs round of T7 RNA polymerase following manufacturer’s directions. 
Briefly, the purified aRNA went through two rounds of amplification with each round consisting 
of the following steps: cDNA synthesis, cDNA purification, in vitro transcription and aRNA 
purification. At the end of the second round of amplification, the quantity and the purity of the 
antisense RNA (aRNA) were measured using NanoDrop
TM
 2000 (Thermo Scientific, Grand 
Island, USA). Also, all aRNA samples were analyzed using the 2200 Tape Station (Agilent 
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Technologies, Santa Clara, USA) for quality control. aRNA samples that showed single, broad 
peak with similar size in length were selected for further analysis. This step was recommended by 
the manufacturer’s instructions to have confidence that selected samples were homogeneous and 
the size of aRNA ranged in length from 200-2000 bases. The aRNA for all samples were stored 
at -80ºC.  
 
4.3.5 Microarray experimental design  
This experiment was designed to evaluate the effect of delaying meiotic resumption  during IVM 
using one of three treatments (cAMP (CA), NPPC+E (NE), and NPPC+E+cAMP (CANE)) 
versus using Pff (standard procedure for IVM) on gene expression of matured oocytes. The 
global transcriptomic profile of treatments versus Pff was performed using the EmbryoGENE 
Porcine Array Version1 (EMPV1, Agilent custom array, NCBI GEO platform GPL14925) [361]. 
The EMPV1 microarray contained a total of 43,675 oligonucleotide probes. Each sample was 
composed of a pool of matured oocytes (approximately 70 oocytes). After RNA extraction and 
amplification, three biological replicates that passed a quality control were used for each group 
(treatment vs. Pff), and the hybridization design was based on the dye-swap design [373]. Each 
biological replicate was stained during labeling with both Cy3 and Cy5 dye and swapped (6 
arrays used per comparison).  
 
4.3.6 aRNA labeling, hybridization and scanning 
The aRNA (2 µg) was labeled with the ULS
TM 
Fluorescent Labeling KIT for Agilent arrays using 
cyanine 3 (Cy3) and cyanine 5 (Cy5) (Kreatech Biotechnology, Amsterdam, Netherlands). The 
procedure was also included purification step using PicoPure
TM  
RNA Isolation Kit (Applied 
Biosystems) to remove unlabelled aRNA. By the end of labeling, the concentration of aRNA and 
dye were measured using NanoDrop 2000 to evaluate the aRNA labeling efficiency. For 
successful hybridization, the labeling efficiency needs to be in minimum of 30 pmol/µg of 
labeling signal.   
Before the hybridization, the fragmentation of labeling aRNA was run by mixing 825 ng of Cy3 
and Cy5 labelled of amplified aRNA, Tomato and Agilent spikes, nuclease-free water plus 25X 
Fragmentation Buffer, and 10X blocking agent (Agilent Technologies). The fragmentation mix 
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(55 µl) was incubated at 60ºC for 15 min and cooled on ice for one min. To stop the 
fragmentation reaction, an equal volume of 2x GEx Hybridization Buffer HI-RPM (Agilent 
Technologies, Santa Clara, USA) was added to fragmentation mix (total 110µl). This final mix 
was loaded into each array of EMPV1 microarray (4 x 44K slide, Agilent). The microarray slide 
was hybridized and washed following the protocol described by Tsoi et al. [361].  
The microarray slides were scanned using GenePix
®
 4200 AL Microarray Scanner (635nm for 
Cy5 and 532 nm for Cy3) with Autoloader (Molecular Device, Sunnyvale, USA). The auto scan 
image was analyzed using GenePix Pro 4.0 software. Any spots (set with pixel size of 5μm) of 
the array with blemishes were manually flagged for exclusion in further analysis. The data for 
analyzed was saved in GenePix Results (GPR) format for further array analysis.  
 
4.3.7 Microarray statistical analysis  
Signal intensity data (median intensity value) was analyzed using the FlexArray software version 
1.6.3 [374], which is based on the Linear Models for Microarray (limma) Bioconductor package 
[375]. Data intensity was uploaded to FlexArray as a median. For background correction, the 
subtraction method (simple) was performed by replacing negative value with 0.5 to avoid 0 or the 
negative values that can interfere with the log transformation performed during the analysis. For 
normalization, Loess within-array and quantile between arrays methods were applied. Limma 
data analysis was run to estimate fold changes of the treatments, which were compared to the 
control (Pff) using fold change value of ≥ 2 and a P-value of ≤ 0.05 as a threshold. The data of 
three comparisons (CA, NE, and CANE) was analyzed using the False Discovery Rate (FDR) 
method and no genes were found differentially expressed after application of the FDR correction. 
 
4.3.8 Gene functions 
The list of genes that were differently expressed was imported into the Expression Analysis 
Systemic Explorer (EASE; http://david.niaid.nih.gov/david/ease/help.htm) to identify gene 
ontology categories that are overrepresented in annotation classes [376]. The statistical analysis 
for over-represented goups was performed based on EASE score (Modified Fisher Exact Test) 
and Bonferrroni correction. Categories with an EASE score of less than 0.05 were considered 
significant. Also, the pathway analysis was performed using Database for Annotation, 
Visualization and Integrated Discovery (DAVID, version 6.7; https://david.ncifcrf.gov/)) tools 
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[377]. This program used an algorithm to measure relationships among the annotation (DAVID 
default population background) terms based on the degrees of their co-association genes, and to 
group the similar annotation contents from the same or different resources into clusters. Also, the 
PANTHER 9.0 program (http://pantherdb.org) was used to identify functional annotations using 
overrepresentation statistical analysis [378]. In these programs, data were different at a P value ≤ 
0.05.  
 
4.3.9 Quantitative-PCR (qPCR) analysis 
For microarray validation, total RNA were taken from three biological replicates of each 
treatment (non-amplified original materials) and converted to cDNA with ReadyScript ®cDNA 
Synthesis Mix with RNase inhibitor (Ambion, Burlington, Canada) according to the 
manufacturer’s recommendations. Based on literature review, qPCR was performed on 10 genes 
(Table 4.5) having a significant differential expression in treated-oocytes. The sequences for 
these selected genes were retrieved from FASTA in NCBI. Primers for selected genes were 
designed using the NCBI’s primer-blast software (http://www.ncbi.nlm.nih.gov/tools/primer-
blast ) and BLAST analysis was performed using the NCBI database 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). Selected primers had to meet the following criteria: 
primer designed to include primer span exon-exon junction; base length of: 20-24 base; CG 
content of: 50-60%; annealing temperature of: 55-65ºC; and amplicon size of: 80-150 bp. These 
primers were commercially synthesized by Integrated DNA Technologies Inc. (IDT, Coralville, 
IA, USA). The qPCR was performed in Rotor-Gene Q (Qiagen,Valencia,USA) using a Rotor-
Gene SYBR Green RT-PCR Kit (Qiagen). The standard curve of each gene was evaluated using 
five serial dilutions of cDNA. The gene expression was normalized using three reference genes 
(PPIA, GUSB, PRL15). These genes have been commonly used as reference genes in different 
studies [379, 380]. In our microarray data, these reference genes also did not differ in our 
treatment groups. The gene expression was calculated based on the comparative CT method 
(∆∆CT) [381] . The statistical analysis of different genes in qPCR was run using a Kruskal-
Wallis Rank Sum Test by comparing the values of specific genes in treatment versus Pff (control) 
using a P value ≤ 0.05.  
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4.4 Results  
4.4.1 Gene expression profile analysis of different treatments 
A total of 55, 120, and 167 genes were differently expressed in CA, NE, and CANE treatment, 
groups respectively, compared to the control group (Pff), (fold change ≥ 2 and P value ≤ 0.05; 
Fig. 4.1-A). The number down-regulated genes were 14, 36, and 112 genes, while the up-
regulated genes were 41, 84, and 55 genes for CA, NE, and CANE, respectively. The three 
treatments had only one gene in common (5.8S ribosomal RNA gene; down- regulate in all 
treatments). Between treatments, the number of genes found to be in common was CA vs CANE 
=3, NE vs CANE =5, CA vs NE =25 (Fig. 4.1).   
 
4.4.2 Gene ontology and pathway analysis 
The EASE program classified the genes into different ontology categories (Table 4.1). The up-
regulated genes in the CA group (Table 4.1) highlighted the effect of cAMP on the signal 
transduction (ARHGAP9, RGS5, BRAO, STAT2, and STAT4), chromosome segregation (TTK 
and RFC3), and mitochondrial activity (TIMM9, MRPS30, MRPL3, and IDH3B). With the NE 
treatment, the results indicated that mostly genes related to nucleus metabolism were up-
regulated. Some of these genes were related to MAPK pathway activity (MAX, MAPK9, REL) 
or the ERK pathway (HAT1). The CANE treatment affected genes that regulate metabolism 
(APOA1, APOD, ACO2, CKMT2, DNAH14, and NDUFB7).  This NE treatment also enhanced 
the pathways involved in growth and cell survival by up-regulating IGF1 and ID4 genes. The 
DAVID program was used to identify the most significant genes involved in different pathways 
(Table 4.2). It was observed that the CA treatment significantly up-regulated JAK/STAT and 
interleukin pathways (STAT2 and STAT4 genes) and the HSP90AA1 gene. In the NE treatment, 
many genes were involved in the metabolic processes (PPARG, IDH3B, and SETDB1) or cell 
cycles (CCNB2 and CDK1), while the CANE treatment up-regulated genes in growth (IGF1 and 
ID4) and metabolic processes (ACO2, APOA1, and CKMT2).  
On the other hand, delaying the meiotic resumption strategy down-regulate genes in different 
treatments (Table 4.3). The NE treatment down-regulated genes involved in fatty acid (SCD5), 
lipid (PLA2G7), and tyrosine (MIF) metabolisms or ATP synthesis (ATP5B). Only the 
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interleukin 18 gene was down-regulated by CA treatment. Meanwhile, CANE treatment 
suppressed genes that had roles in signal transduction pathways (IL6, HBEGF, and TLR7)  
The PANTHER program was used to understand the pathways that were over-represented in each 
treatment (Table 4.4). This analysis showed that CA treatments up-regulated pathways related to 
signal transduction (JAK/STAT, interleukin, and PDGF pathways), while NE treatment up-
regulated genes more related to cell growth and survival. For CANE, up-regulated the pathways 
involved in the mannose metabolism, TCA cycle and integrin signaling. Also, the cytoskeleton 
regulation pathway affecting the intracellular cytoskeleton in the cell was also up-regulated.   
 
4.4.3 qPCR validation 
PCR validation failed to demonstrate significant differences in the gene expression between 
microarray and qPCR analytical tool (Fig. 4.2). Most trends in expression genes in qPCR 
followed the same pattern of microarray except for two genes: RGS5 (Incresed in microarray vs 
decreased in qPCR) .and SCD5 (Decreased in Microarray vs increased in qPCR).  
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Table 4.1: The EASE analysis results of up-regulated genes from different groups that involve in different 
ontology categories. 
 
System 
Gene 
Category 
EASE score Genes 
C
A
 v
s 
P
ff
 
 
 
GO Cellular 
Component 
cytoplasm 1.72E-02 
BRAP; CHIC2; IDH3B; MRPL3; MRPS30; 
RFC3; RGS5; STAT2; STAT4; TIMM9; TTK 
GO Molecular 
Function 
enzyme 
activator 
activity 
2.31E-02 ARHGAP9; RFC3; RGS5 
GO Biological 
Process 
JAK-STAT 
cascade 
3.48E-02 
 
STAT2; STAT4 
 
N
E
 v
s 
P
ff
 
GO Biological 
Process 
DNA 
metabolism 
2.29E-03 
ASF1A; CRY1; HAT1; PMS1; SETDB1; SPO11; 
UBE2A 
GO Cellular 
Component 
nucleus 2.45E-03 
ASF1A; CCNB2; CFL2; HAT1; MAPK9; MAX; 
PMS1; PPARG; PSMD5; REL; SETDB1; 
SPO11; TAF13; TRIP4; UBE2A; ZNF277 
GO Biological 
Process 
nucleotide 
and nucleic 
acid 
metabolism 
1.26E-02 
ASF1A; CRY1; HAT1; MAX; PAICS; PMS1; 
PPARG; REL; SETDB1; SPO11; TAF13; TRIP4; 
UBE2A; ZNF277 
C
A
N
E
 v
s 
P
ff
 
GO Molecular 
Function 
high-density 
lipoprotein 
binding 
1.73E-02 APOA1; APOD 
GO Cellular 
Component 
cytoplasm 1.97E-02 
ACO2; ACTA1; ACTA2; AP2B1; APEH; 
CKMT2; DAP3; DNAH14; DTNB; EXTL2; 
GMDS; ITGA6; NDUFA9; NDUFB7; PDLIM1; 
PLP2; PRKRA; RGS5; RPS8; S100A12; SNX3 
GO Biological 
Process 
cell motility 2.33E-02 AAMP; ACTA1; CKMT2; FN1; IGF1 
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Table 4.2: The functional pathway analysis from DAVID program showing significantly up-regulated 
genes involved in pathways associated with different treatment groups. 
N
E
 v
s 
P
ff
 
Gene 
names 
(log2 fold 
change) 
Pathways 
C
A
 v
s 
P
ff
 
Gene 
names 
(log2 fold 
change) 
Pathways 
C
A
N
E
 v
s 
P
ff
 
Gene 
names 
(log2 fold 
change) 
Pathways 
SETDB1(
1.36)  
Lysine 
degradation 
IDH3B 
(1.03) 
Citrate cycle(TCA 
cycle) 
ACO2 
(1.04) 
1-Citrate cycle (TCA 
cycle), Glyoxylate and 
dicarboxylate 
metabolism  
CDK1 
(1.08)  
Cell cycle,  
Oocyte meiosis, 
p53 signaling 
pathway, Gap 
junction, 
Progesterone-
mediated oocyte 
maturation  
HSP90- 
AA1 
(1.05) 
Antigen processing 
and presentation, 
NOD-like receptor 
signaling pathway, 
Progesterone-
mediated oocyte 
maturation, 
pathways in cancer, 
Prostate cancer 
APOA1 
(1.82) 
PPAR  signaling 
pathway 
CKMT2(
1.01) 
Arginine and proline 
metabolism  
CFL2 
(1.18) 
Lysine 
degradation  
ID4 
(1.01) 
TGF-beta signaling 
pathway  
IGF1 
(1.91)  
Oocyte meiosis, p53 
signaling pathway, 
mTOR signaling 
pathway, Focal 
adhesion, Long-term 
depression, 
Progesterone-mediated 
oocyte maturation, 
Aldosterone-regulated 
sodium reabsorption 
Pathways in cancer, 
Glioma, Prostate 
cancer, Melanoma, 
Hypertrophic 
cardiomyopathy  
(HCM), Dilated 
cardiomyopathy  
CCNB2 
(1.24)  
Cell cycle, 
Oocyte meiosis , 
p53 signaling 
pathway, 
Progesterone-
mediated oocyte 
maturation 
STAT2 
(1.11) 
Chemokine signaling 
pathway, Jak-STAT 
signaling pathway  
STAT4 
(1.12) 
Jak-STAT signaling 
pathway 
IDH3B 
(1.10) 
Citrate cycle  
 PPARG 
(1.02) 
PPAR signaling 
pathway, 
Huntington's 
disease, 
Pathways in 
cancer, Thyroid 
cancer,  
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Table 4.3: The functional pathway analysis from the DAVID program showing significantly down-
regulate genes involved in pathways associated of different treatment groups. 
N
E
 v
s 
P
ff
 
Gene 
names 
(log2 fold 
change) 
Pathways 
C
A
 v
s 
P
ff
 
Gene 
names 
(log2 fold 
change)  
Pathways 
C
A
N
E
 v
s 
P
ff
 
Gene 
names 
(log2 fold 
change) 
Pathways 
IL18 
(-1.31) 
Cytokine-cytokine 
receptor interaction, 
NOD-like receptor 
signaling pathway, 
Cytosolic DNA-
sensing pathway 
 IL18 
 (-1.02) 
Cytokine-
cytokine receptor 
interaction, 
NOD-like 
receptor 
signaling 
pathway, 
Cytosolic DNA-
sensing pathway 
IL6 
(-1.18) 
Toll-like receptor 
signaling pathway, 
NOD-like receptor 
signaling pathway, 
Cytosolic DNA-
sensing pathway, 
Jak-STAT signaling 
pathway, 
Hypertrophic 
cardiomyopathy 
(HCM) 
MIF 
(-1.75) 
Tyrosine 
metabolism, 
Phenylalanine 
metabolism 
 
HBEGF 
(-1.24) 
ErbB signaling 
pathway, GnRH 
signaling pathway 
BLM 
(-1.17) 
Homologous 
recombination, 
PLA2-G7 
(-1.99) 
Ether lipid 
metabolism 
PPP1CB 
(-1.25) 
Oocyte meiosis, 
Vascular smooth 
muscle contraction, 
Focal adhesion, 
Long-term 
potentiation, 
Regulation of actin 
TLR7 
(-2.27) 
Toll-like receptor 
signaling pathway, 
PSME2 
(-1.16) 
Proteasome 
Antigen, processing 
and presentation 
SCD5 
(-1.03) 
Biosynthesis of 
unsaturated fatty 
acids, PPAR 
signaling pathway 
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Table 4.4: Results of pathway analysis of gene expression in matured oocytes in different treatment 
groups. Statistical overrepresentation test was used in the PANTHER program to identify the most 
significant pathways from the gene list.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Pathway genes P-Value 
U
p
-r
eg
u
la
te
d
 g
en
es
 
N
E
 
Circadian clock system 
 
CRY1 
 
2.39E-02 
Oxidative stress response 
 
MAX, MAPK9 
 
2.47E-03 
Toll receptor signaling 
 
REL, MAPK9 
 
1.01E-02 
Ubiquitin proteasome 
 
UBE2A,UBA2
T 
1.27E-02 
Apoptosis signaling 
 
REK,MAPK9 
 
3.86E-02 
EGF receptor signaling 
 
MAX,DAB21P 
 
4.81E-02 
C
A
 
JAK/STAT signaling 
 
STAT2, 
STAT4 
4.97E-04 
Interleukin signaling 
 
STAT2,STAT4
, BRAF 
3.46E-04 
Ras signaling 
 
STAT4, BRAF 
 
5.27E-03 
PDGF signaling 
 
STAT2,STAT4
, BRAF 
9.09E-04 
C
A
N
E
 
EGF receptor signaling 
 
STAT2, 
STAT4 
1.41E-02 
Mannose metabolism 
 
GMDS 
 
1.63E-02 
TCA cycle 
 
ACO2 
 
2.43E-02 
Integrin signaling 
 
FN1, ITGA6 
 
 
Cytoskeletal regulation by 
Rho GTPase 
ACTA1, 
ACTA2 
4.03E-02 
D
o
w
n
-r
eg
u
la
te
d
  
g
en
es
  
N
E
 
ATP synthesis ATP5B 1.62E-02 
Endogenous_cannabinoid 
signaling 
 
GNG11 2.3E-02 
C
A
 
Toll receptor signaling 
 
IL18 2.71E-02 
C
A
N
E
 Asparagine and aspartate 
biosynthesis 
ASNS 2.80E-02 
Coenzyme A biosynthesis  PANK3 4.36E-02 
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Table 4.5:  Oligonucleotide primer sequences that were used for real-time qPCR analysis to validate 
microarray results  
 
 
 
 
Gene Accession# Oligo Primer sequence 
Amplic
on size 
(bp) 
Anneali
ng 
tempera
ture(ºC) 
STAT4  
NM_0019730
5.1 
Forward 
Reverse  
CATGTATGCCAACCCACCCT 
TGCTGAGAGTTGAAACATTCTTGT 
 
150 
60.03 
59.12 
BRAF  
XM_0031346
10.3 
Forward 
Reverse  
AACTTGATTTGCTGTTTGTCTCCA
AGGCTGTGGGATTGGAATGG 
 
182 
59.60 
60.00 
HSP90A
A1  
NM_213973.1 
Forward 
Reverse  
TGTCAGTCACCAAAGAGGGC 
CGACACAACCACCTTTTCGAC 
 
143 
59.90 
60.00 
MRPL3  
XM_0019250
38.3 
Forward 
Reverse  
CAGGAACTTGGATTGCCTCC 
ATAGAGGGGTGCCTGGCTTA 
 
85 
58.53 
60.03 
CDK1  
NM_0011593
04.2 
Forward 
Reverse  
AAGCTGGGATCTACCACATCCA 
CATGGCTACCACTTGACCTGT 
 
128 
60.90 
60.00 
SCD5  
NM_0011142
78.1 
Forward 
Reverse  
CACCGTCTCACTCAACGTCA 
TTGTGGAAGCCTTCACCGAT 
 
135 
59,97 
59.60 
PPARG  NM_214379.1 
Forward 
Reverse  
TCCATGCTGTCATGGGTGAA 
ACCATGGTCACCTCTTGTGA 
 
103 
59.05 
60.25 
RGS5  NM_214356.1 
Forward 
Reverse  
CGGAGGCTCCTAAAGAGGTGA 
GAAGCGAGGCAGTGAATCCT 
 
143 
60.96 
60.11 
IGF1  NM_214256.1 
Forward 
Reverse  
GCCCAAGGCTCAGAAGGAAG 
GAGCAAAGGATCCTGCCAGT 
 
130 
60.68 
60.03 
ACO2  NM_213954.1 
Forward 
Reverse  
CGAGTAGGTCTGATCGGCAG 
GAGCCCGGTGTGATGGTAAA 
 
128 
59.69 
60.04 
PPP1CB  NM_214184.2 
Forward 
Reverse  
TCTGTTGTCACGGAGGACTGT 
CCCCAACCTTGCACATCCTTA 
 
142 
61.03 
60.27 
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Fig. 4.1: Venn diagram summarizing number of known genes after microarray analysis of porcine 
matured oocytes that were delayed meiotic resumption using different treatments during in vitro 
maturation in comparison to the Pff group (control). Up- and down-regulated of known genes were 
determined using fold change of ≥ 2 and P ≤ 0.05.  
. 
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Fig. 4.2: The expression of different genes (log of fold change) from matured oocytes after delaying 
meiotic resumption during IVM using qPCR (three biologic replicates /for each treatment). Solid bars 
represent the expression (± SEM) of genes by qPCR. The open bars represent the expression of the same 
group of genes measured by microarray. *The value is significantly different (P ≤ 0.05) in treatment 
groups compared to control 
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4.5 Discussion 
The present study was to identify the effect of delaying meiotic resumption protocol after IVM on 
gene profile of porcine oocytes in compared to using standard procedures (Pff). It could be 
expected that CANE treatment would have many differentially expressed genes and pathways in 
common with the CA and/or NE treatments because CANE was a combination of CA and NE 
treatments. However, the results showed a very limited number of differentially genes in common 
between CANE and other treatments (Fig. 4.1). Previous studies have reported that the 
interaction of estradiol with dbcAMP can affect gene expression regulation differently [382-384]. 
Estradiol mediates its effect in oocytes through receptors that modify gene transcription [385]. 
However, it was observed that PKA stimulated by cAMP can modulate estradiol receptor (ER) 
response through phosphorylating the ER residues [382]. Therefore, both estradiol or cAMP  can 
modulate the ER response differently in term of gene expression pattern [383]. All steroid 
receptors including ER are ligand-activated transcription factors that can be activated by non-
steroid hormones [386]. The ability of cAMP to elicit ER response is a ligand-independent 
manner that can lead to specific gene expression  response [383]. As an example of this different 
interaction, a study investigating the expression of estrogen receptors (ESR2a and IHCGR) in 
ovarian follicles of zebrafish when treated with dbcAMP (1 mM) and estradiol (50 nM) [387]. 
Treated oocytes had different gene expressions in comparison of the use of both substances 
individually. These findings could explain the limited number of common genes between CANE 
and other treatments for our study (Fig. 4.1). The use of threshold (two-fold) to establish a list 
differentially expressed gene list could be another explanation for the few number of common 
genes between CANE and other treatments. Using 1.5 fold changes, our analyses revealed more 
common genes between CANE and other treatments (data not shown). However, the number of 
common genes discovered with a lower cut-off was still limited. Regarding the common genes 
between the other groups, it was observed that CA and NE treatments had 25 common genes, 
which represent 42 % or 19% of the total population of differentially expressed genes, 
respectively. Except for MRPL3, most of these common genes did not show any direct effects on 
oocytes competence. MRPL3 was found to be associated with an increase of oocyte competence, 
by influencing the transcription of other genes involved in oocyte development [388]. This 
conclusion was established based on many previous microarray studies that compared matured 
oocytes under in vitro and in vivo conditions for bovine and mouse [389]. Our data clearly has 
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shown that each treatment used to delay meiotic resumption has a unique impact on the molecular 
pathway to improve the oocytes competence.      
The dbcAMP that used to delay meiotic resumption of cattle and pigs oocytes [10, 359] has 
shown increasing the number of in vitro produced embryos. Our study has shown that treating the 
oocyte with CA during in vitro maturation (first 22 hrs), resulted in up–regulation of different 
pathways related to an increase of the mitogen-activated protein kinase (MAPK) pathway activity 
(Table 4.4). The Ras, JAK/STAT and PDGF pathways were up-regulated and found to be 
involved in MAPK pathways. These pathways consist mainly of three genes (STAT2, STAT 4 
and BRAF); these genes are involved in MAPK activities [390]. This result supports previous 
studies [227, 391] that using dbcAMP to delay nuclear maturation for 22 hrs will increase 
mitogen-activated protein kinase (MAPK) in pig oocytes by 44 hrs of IVM, and modulated the 
intracellular signal pathways in responses extracellular signals [392, 393]. This transduction 
signal induces an activation of PI3 kinases (phosphatidylinositide 3-kinases), which are usually 
involved in cellular proliferation, development, and activation of the anti-apoptotic process in 
oocytes [390, 394]. Therefore, up-regulated genes that are involved in MAPK activity can reflect 
positively in our study of oocytes by up-regulating genes such as the heat shock protein 90 
(HSP90AA1) and mitochondrial ribosomal protein L3 (MRPL13). These genes play a role in 
oocytes competence [389]. Inhibition of HSP90AA1 during IVM reduced the developmental 
competence of bovine oocytes and negatively affected the blastocyst rate [395]. Also, MRPL3 is 
considered a gene marker for oocyte competence [388], and was up-regulated in our study. Thus, 
the elevation of expression of the MRPL3 and HSP90AA1 genes observed in the CA group could 
suggest that they can support oocyte competence without the presence of Pff. 
Treating pig oocytes with NE  to delay oocyte meiotic resumption  has been shown to up-regulate 
different MAPK pathway signaling genes (MAX, MAPK9, and REL) [396-398]. The importance 
of the expression of these genes is related to their roles in meiotic maturation, development of 
oocyte in mammalian [390, 399]. It has also been established that estradiol can induce a rapid 
activation of MAPK in mammalian cells with an event that is independent in terms of 
transcription and protein synthesis [400, 401]. Also, the NE treatment up-regulated  the oxidative 
stress response, which prevents Reactive Oxygen Species (ROS) damage in oocytes during IVM 
[402]. This response could protect the oocytes from damage and has a positive effect on oocytes 
development and competence. Therefore, the up-regulation of gene activities induced by NE 
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treatment could support the growth and development of oocytes, and indirectly support the 
embryo development. 
The CANE treatment significantly up-regulates genes involved in the metabolic process, growth, 
and cell survival (Tables 4.1, 4.3, 4.5). Interestingly, the CANE treatment significantly increased 
IGF1 gene expression, which has been found to improve the competence of oocytes in different 
species including pigs [403] bovine [404] and mice [405]. Increasing this growth factor’s 
expression may play an important role in improving oocyte competence and achieving a 
successful IVF–IVC process, as we previously demonstrated with a similar blastocyst rate using 
CANE treatment compared to Pff (Chapter 3).  
In general, all treatments used in this study activated many metabolic processes at different levels 
(Table 4.1, 4.2, and 4.4).  During IVM, the oocytes usually go through many intracellular 
changes toward maturation that require energy consumption [302, 406]. These result are in 
agreement with a study of mouse oocytes that found the genes controlling metabolism are up-
regulated in MII when compared to the GV stage [295]. The metabolic processes associated with  
oocytes development plays an important role in determining oocyte competence [52].   
In summary, this study demonstrated that different methods used to delay meiotic strategy will 
have their own molecular effect leading to the maturation of pig oocytes. Among the treatments 
tested in this study, only a few molecular pathways (metabolic process and growth and cellular 
development) were common among the group. Same phenomenon was observed when we 
specifically analyzed the gene expression, only one gene was common and highly expressed 
between the treatments (5.8S ribosomal RNA). Regardless of the strategy used to delay meiotic 
resumption, it will lead to a same in vitro development of pig embryos (Chapter 3).   
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Relationship of this study to the dissertation 
In previous studies, we highlighted the importance of the strategy of delaying meiotic resumption 
in improving the porcine embryo production in vitro. Also, the ability to cryopreserve the 
embryos for both long and short term safely and without contamination has presented another 
challenge in pig IVP. In this study, I examined two vitrification methods dependent on direct 
contact with liquid nitrogen (Open–pulled straws, OPS) or no contact (French straw, FS) that 
reduced the possibility of contamination by liquid nitrogen. The study evaluated the effect of 
vitrification procedures on embryo quality and viability. We hypothesized that embryos 
produced in vitro would survive the vitrification processes at an equivalent rate whether using a 
closed (FS) or an opened device (OPS). 
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5.1 Abstract 
Pig embryos have been vitrified successfully after direct exposure of embryos to liquid nitrogen 
using open pulled straws or cryoloop. Using an open carrier, vitrified pig embryos can be 
contaminated from pathogenic organisms that could be contained into the liquid nitrogen vessel. 
This study hypothesized that in vitro produced embryos would survive vitrification procedures at 
an equivalent rate using a closed (French straws (FS)) or an open device (Open Pull Straw 
(OPS)). In vitro derived morulas were produced using standard procedures and vitrified on day 5 
of in vitro culture (FS; n=127, OPS; n=115). The quality of the embryos (morphological 
integrity) was evaluated after warming and after 48 hours of culturing. After warming, 85% of 
vitrified embryos showed a quality of grade 1 for both FS and OPS groups. After 48-hr of 
culture, morulas did not develop to a blastocyst stage. The number of embryos stained with 
propidium iodide (PI) increased significantly (P = 0.02) with OPS compared to FS. Morulas of 
quality of grade 1 decreased to 70% for FS group and 63% for OPS group.  In conclusion, in 
vitro produced embryos can be efficiently vitrified using a closed system and be stored in 
biosecure manner enabling distribution or long-term storage using a closed system. 
 
5.2 Introduction  
Cryopreservation of pig genetic material (oocytes, semen, and embryos) is a valuable method 
used to preserve the genetic diversity of pig breeds [407]. Many advantages can be gained from 
this process, including: the protection of genetic material of a species or breed from the risk of 
outbreak disease, the reduction in the transportation cost compared to live animals, and 
applications in both research in bio-medicine and reproductive technologies [313, 408]. 
Vitrification is a technique that uses a rapid cooling process by direct transfer into liquid nitrogen 
[305]. Oocytes [409], sperm [410], embryos [411] and reproductive tissues [412] derived from 
pigs have been successfully preserved using this technique. From a conservation point of view, 
vitrified embryos are preferable to oocytes or semen due to the ability to preserve the entire 
genome of an animal. The success in preserving pig embryos in the short- or long-term using 
vitrification can be considered one of essential elements of an effective embryo transfer industry 
[281]. Although the embryo transfer in the pig was limited in commercial work for a long time 
due to unavailability of an acceptable nonsurgical method, successes were reported recently 
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[413, 414]. Research on vitrification process is important to deliver viable embryo and to be used 
in embryo transfer whenever it is required.  
Successful cryopreservation of porcine embryos, however, faces obstacles due to their high lipid 
content, which makes them very sensitive to chilling damage [415, 416]. This sensitivity is 
related to the stage of embryonic development [417]. Blastocysts and morulas have been 
reported to be less sensitive than earlier 2–4 cell stages, because the lipid content is reduced as 
embryo development progresses [315]. Vitrification procedures were demonstrated to deliver 
more viable pig embryos for using in different applications such as embryo transfer and 
biomedical studies. The reason for successful vitrification of pig embryos is the extreme rate of 
cooling (up 20,000 ºC/min), which prevents chilling injuries associated with the lipid contents in 
the cells [308, 418]. Various methods have been used to vitrify embryos, which can be classified 
into two types based on vitrification device used to load the embryos [313]: open and or closed 
system devices [419]. In closed system devices such as conventional French straw (FS), embryos 
have no direct contact with liquid nitrogen (LN2) and they are frozen at a rate of 2,500ºC/min 
[420]. On the other hand, open devices such as the Open pulled straw (OPS) allow direct contact 
of embryos with LN2 and the embryos are frozen at a rate of 20,000ºC/min [420, 421]. The high 
cooling rate prevents chilling injury to cells and reduces the exposure time of embryos to 
cryoprotectants, reducing toxicity effect in embryos [419, 422]. Open system devices have been 
used successfully to vitrify pig embryos, resulting in live piglets [423-427]. However, there are 
biosecurity concerns associated with direct exposure of the embryos to LN2, which can be 
contaminated by fungal spores, yeasts, bacteria, and viruses [428-430]. Theoretically, the 
contamination can occur even with sterile LN2 due to the risk of cross-contamination with 
infected samples [431]. This contamination risk may limit the vitrification technique from being 
commercially used in swine industry and it is contrary to the recommended procedures for 
international distribution (requiring a closed device for the frozen embryos [432]). Many reports 
have indicated that using sealed carriers during cryopreservation is effective in protecting the 
germplasm from contamination, compared to the use of open carriers [430, 431, 433, 434]. The 
goal of this study was to compare the ability of in vitro produced embryos at morula stage to 
survive vitrification procedures using an opened (OPS) or closed (FS) device and to develop 
normally under in vitro conditions. Specifically, we hypothesized that in vitro produced morulas 
will survive the vitrification procedures and develop to blastocyst at the same rate. The objective 
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of this study was to evaluate the ability of in vitro produced embryos to survive vitrification 
procedures with a closed or opened carrier. 
5 3 Material and methods  
5.3.1 Chemicals and media 
All the chemicals and media were purchased from Sigma Chemical Co, Oakville, Canada ; the 
exceptions were noted in the following sections. 
 
5.3.2 In vitro production of embryos 
Ovaries were collected from prepubertal gilts at a local slaughterhouse and transported to the 
laboratory within two hours, in a thermos containing pouches pre-warmed to a temperature of 
37ºC. Then, the ovaries were cleaned of adjacent tissues and rinsed in saline (0.9% NaCl) three 
times at room temperature. The cumulus oocyte complexes (COCs) were aspirated from follicles 
of 3–6 mm in diameter. Oocytes with a homogeneous cytoplasm and three or more cumulus cell 
layers were selected for this study and transferred into TCM-199 (Invitrogen, Burlington, 
Canada) supplemented with HEPES (25 mM) and antibiotic-antimycotic (1X, Invitrogen). COCs 
were washed three times in this medium, then transferred to a maturation media (TCM-199, 
composed of 0.1% polyvinyl alcohol, 3.05 mM D-glucose, 0.91 mM sodium pyruvate, antibiotic-
antimycotic 1X (Invitrogen), 10 ng/ml EGF, 0.57 mM L-cysteine, 0.01 IU/ml Lutropin-V® 
(Bioniche, Oakville Canada), 10% of porcine follicular fluid, and 0.01 IU/ml Folltropin® 
(Bioniche). The COCs were grouped up to a maximum of 50 and incubated for 44 hrs in a 5% 
CO2, 5% O2, and 90% N2 in a humidified environment at 38.5°C. 
Matured oocytes were washed three times in a modified tris-buffered medium (mTBM) 
supplemented with 1 mM caffeine and 0.4% bovine serum albumin (BSA; Minitube,Verona, 
USA) [435]. For semen preparation, frozen semen straws were thawed at 50°C for 10 seconds, 
diluted with mTBM media, and centrifuged twice at 1000X for 7 min. The concentration of 
sperm added to a group of 50 oocytes was 0.1×10
6
 sperm/mL. After incubation of the matured 
oocytes with sperm for 6 hrs at 38°C (in an environment of 5% CO2, 5% O2 and 90% N2), the 
presumptive zygotes were washed and cultured in NCSU-23 (Zenith Biotech, Guelph, Canada) 
supplemented with 0.4% BSA. These zygotes were incubated in 5% CO2, 5% O2 and 90% N2 in 
a humidified environment at 38°C for 5 days. 
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5.3.3 Vitrification and warming of embryos 
Only morulas of grade 1 were selected for the vitrification procedures (see section 5.3.3 for a 
definition of embryo grade). Two different devices were used: French straw and open pulled 
straw. All the manipulations were performed at room temperature. 
 
5.3.3.1 French straw (FS) method: 
Embryos were vitrified using the French straw (0.25 cc; IVM Technology (Guelph, Canada)). 
The Syngro Bovine Vitrification Kit (Bioniche, Pullman, USA) was used according the 
manufacturer’s instructions. Briefly, the embryos were immersed in two vitrification media: VS1 
and VS2, for 5min and 40–60 sec respectively. While the embryo was placed in VS1, the straw 
was loaded with 95 µl of diluent and filled with an air column of 10 mm. After the embryo was 
transferred from VS1 to VS2, the embryo and a small volume of VS2 solution were drawn into 
the straw. A third column of air was made and the final column of diluent completed the filling 
of the straw before being sealed ultrasonically. Afterward, the straws were suspended for 1 min 
in a container cooled down by the LN2 and the cooled straws were directly plunged into liquid 
nitrogen. These straws were stored in LN2 for a minimum of 2 weeks.   
For the warming procedure, the straw was removed from LN2, left at room temperature for 10 
sec and then placed in warm water (35ºC) for 20 sec. After warming, the content of the straws 
was mixed by flicking (5-7 times) and the straws were incubated in a water bath at 22–25oC for 5 
min prior to wash (3x) and transfer  the embryos to a culture media 48 hrs.  
5.3.3.2 Open pulled straws (OPS) method: 
The protocol for OPS was followed according to the manufacturer’s recommendations (Minitube 
International, Delavan, USA). Three types of media were prepared during the OPS vitrification 
procedure. The first was the holding media (HD) composed of a PBS (X1) supplement with 
0.5% BSA (w/v). The second was the OPS vitrification solution I (OPS-I) contained HD media 
supplemented with 7.5% (v/v) of ethylene glycol (EG) and 7.5% (v/v) dimethyl sulfoxide 
(DMSO). The third media (OPS-II) was a sucrose media (SM, 1M of sucrose dissolved in HD) 
supplied with 16.5% (v/v) of EG and 16.5% (v/v) DMSO. 
Around 3–5 embryos at morula stage were transferred into HD media for 1 min and moved to 
another drop of HD. These embryos were placed in OPS-I and subsequently transferred into a 
small drop (approximately 20 µl) of OPS-II. After a few seconds, the embryos were pipetted 
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with a small amount of media to create a drop of 2 µl. Then, the thin side of the OPS straw was 
used to touch the small drop from the left side at a 30
o
 angle. The embryos transferred into OPS 
by capillary action. Immediately afterward, the OPS were plunged into LN2 horizontally. Then, 
the straws were directly stored in a small holder in LN2 for at least 2 weeks.  
For the warming procedure, HD and sucrose media (SM) (holding media supplement with 1M of 
sucrose) were prepared and all media warmed to 37ºC. After the OPS was taken out from LN2, it 
was held with thumb and middle finger for 3 sec. Then, the OPS from thin part was immersed in 
mixture of HD and SM with a ratio of 2:1(v/v) in 45º angle. Immediately after the vitrified 
solution column melts, the mixture HD: MS media started diffused into the straw. By closing the 
open end with index a finger, the solution that melted containing the embryo flowed in HD: MS 
media. Immediately, the embryos were transferred to another drop with the same mixture for 5 
min.  After that, the embryos were transferred to a mixture of HD and SM with a ratio of 4:1 for 
5 min. The last transfer for the embryos was made into HD media. Finally, the embryos were 
washed in a 3X culture media (described above) before being observed for quality and incubated 
for 48 hrs in NCSU-23.  
 
5.3.4 Evaluation of Embryo Quality 
The quality of the embryos was evaluated based on morphological integrity as described by Bó 
and Mapletoft [336]. All selected embryos for vitrification had a quality of grade 1. After 
warming, the quality of embryos was evaluated and these embryos were transferred into NCSU-
23 for 48 hrs. Embryos were classified into three categories: Grade 1 (G1) had a symmetrical and 
spherical embryo mass with individual blastomeres; Grade 2 (G2) had moderate irregularities in 
the overall shape of embryonic mass or in size, with at least 50% of the cellular material in an 
intact, viable embryonic mass; Grade 3 (G3) had the most embryonic mass irregularities in the 
overall shape, with at least 25% of the cellular material in an intact, viable embryonic mass 
(Fig.5.1). 
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Fig. 5.1: Examples of classifications of post-warmed embryos after 48 hrs of culture. The embryos were 
classified into different grades as follows: Grade 1 (G1) has a symmetrical and spherical embryo mass 
with individual blastomeres; Grade 2 (G2) has moderate irregularities in overall shape of embryonic mass 
or in size, with at least 50% of cellular materials in an intact, viable embryonic mass; Grade 3 (G3) has 
major irregularities in the overall shape of embryonic mass or size, with at least 25% of cellular material 
in an intact, viable embryonic mass. 
5.3.5 Evaluation  on the number of cells that stained with PI): 0, 1-2, 3-4, 5–7, > 8 cells. 
5.3.5 Evaluation of Embryo Viability 
The viability assessment was performed by evaluating cell permeability to propidium iodide (PI) 
[400]. At the end of the culture, the embryos were washed three times in PBS 1X supplemented 
with 1% PVA. After washing, the embryos were transferred to a staining solution (washing 
buffer supplemented with 12 µM of PI) and incubated for 7-8 min at 37
o
C in the dark. Then, the 
embryos were washed again five times in washing buffer. Each morula was observed under 
fluorescent microscopy to assess the number of cells stained with PI. They were then classified 
into five categories depending on the number of cells stained: 0, 1-2, 3-4, 5–7, > 8 cells. 
 
5.3.6 Statistical Analysis 
Statistical analysis was performed using SAS 9.2 (SAS Institute Inc., Cary, NC, USA). The 
effect of vitrified procedures on the number of fluorescent spots in embryos and the quality of 
embryos were analyzed using a chi square method followed by Fisher's least significant 
difference (LSD) test. A P-value ≤ 0.05 was considered significant 
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5.4 Results 
5.4.1 Quality of Embryos 
In total, 242 embryos were in vitro produced and vitrified using OPS (n=115) or FS (n=127) 
devices. After vitrification and warming procedures, no differences in the quality of the embryos 
were found between the devices. Around 85% of the morulas maintaining the quality of G1 
(Table 5.1). After 48 hrs of culture, morulas did not progress to a blastocyst stage (data not 
shown). The number of morulas of G3 increased and was significantly different between the 
carrier devices used for vitrification (P = 0.02). Also, the number of embryos of G1 was reduced 
when compared to after warming (FS, P = 0.004 and OPS , P < 0.001). This reduction of grade 1 
quality between 0 and 48 hrs exhibited the same pattern in both methods. 
 
 
Table 5.1: Effect of vitrification-warming procedures using FS (French straw) or OPS (Open–Pulled 
Straws) devices on the quality of morulas after warming (0 hr) and after culturing (48 hrs). Morulas were 
classified based on their quality: grade 1 (G1), grade 2 (G2), grade 3 (G3). Values with different letter or 
number were significantly different (P ≤ 0.05). The small letter shows the difference within the grade, the 
number shows the difference between 0 and 48hrs in G1  
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5.4.2 Permeability of the Cells to PI 
After 48 hrs of culture, a majority of the morulas (over 70%) had 2 or lower number of cells 
stained with PI (Fig. 5.2). Interestingly, embryos vitrified with FS device had greater proportion 
of embryos without fluorescent red spots (P = 0.03) compare to OPS device. Also, the morulas 
vitrified with OPS had a higher proportion of stained cells (5–7 red spots; P = 0.02) than 
embryos vitrified with FS. No differences were observed with the other categories (1-2, 3-4, > 8 
red spots groups) between embryos vitrified with OPS and FS. 
 
 
 
Fig. 5.2: Cellular integrity of vitrified embryo with OPS or FS after warming and culturing for 48 hrs. (A) 
Proportion of morulas classified based on the number of PI-stained cells:  0, 1-2, 3-4, 5–7, or > 8 cells). 
(B) Examples of pictures of morula at 0 hr (1), 48 hrs (2), morula after PI staining (3), and dead morula 
after PI staining (4).
 
 Device with different superscript were statistically different (P ≤ 0.05). 
 
 
 82 
 
5.5 Discussion  
Based on embryo quality (Table 5.1) and cell integrity (Fig. 5.2), this study demonstrated that in 
vitro produced embryos can survive the vitrifying-warming procedures regardless of the device 
used for vitrification. The majority of the vitrified embryos kept their quality of grade 1 after 
warming and culturing (Table 5.1). These results suggest that the different vitrification 
procedures induced minimum structural damages to the embryos. However, in vitro produced pig 
embryos vitrified with OPS had a higher proportion of morula of grade 3 after 48 hrs of culture, 
suggesting that vitrification using FS could potentially offer a better protection against the 
cryodamage.  
In this study, PI permeability was used as a cell viability assay [436] and it is well known that 
different cell viability assays could generate different results [437]. Therefore, it is possible that 
these embryos were more affected by the vitrification processes that we observed, which could 
explain the arrest in the development for the morulas observed after 48 hrs of culture. However, 
this observation could also be explained by the suboptimal culture conditions of the in vitro 
production system or the source of oocytes. Suboptimal culture conditions still remain a major 
factor affecting the yield and quality of pig embryos obtained in vitro [438, 439] which is less 
than the production rate obtained in the bovine species. The average blastocyst formation derived 
from IVP in pigs is around 20% [440] compared in bovine blastocyst rates around 35% [215]. 
Also, the source of oocytes used in this study could be considered another factor to explain the 
arrest in development of the embryos. Embryos in this study were derived from oocytes from 
prepubertal gilts. It has been demonstrated that these oocytes had a lower competency compared 
to those obtained from sows [441]. This lower competency is reflected by a low embryo 
development [442] caused by insufficient cytoplasmic maturation or increase of polyspermia 
[190, 201]. Another factor that could interfere in the development of the morulas could be related 
to their lipid content [411]. Compared to in vivo produced embryos, the lipid content is higher in 
embryos produced in vitro [443]. This amount of lipid can affect the survival rate of an embryo if 
it is not removed before the freezing procedures [314, 444]. In this study, the lipids were not 
removed and it could explain the lack of development of morulas to blastocysts after 48 hrs of 
culture. To determine if the vitrified-warmed morulas are functional, the ultimate evaluation 
would be to transfer these vitrified-warmed embryos in a recipient and determine the pregnancy 
rate after a determined period. However, it was not the scope of this study. 
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There was concern in our design that low cooling rate of close carrier (FS) could affect 
negatively on embryo quality or cell integrity [445]. However, the results of embryo quality after 
warming did not show any difference between using closed and opened carriers for vitrification. 
These results indicated that the range of cooling rates of 2,500 ºC/min for FS and 20,000ºC/min 
for OPS is equivalently efficient to vitrify the embryos without causing too much damages. 
Different reports demonstrated that pig embryos of different development stages did not show 
differences in the embryo survival rate after vitrification and warming [314, 444, 445]. Thus, this 
study confirms that at least 2,500 ºC/min is sufficient to vitrify in vitro produced pig embryos at 
a morula stage.  
In this study, the results of embryo quality and cells permeability show that the using FS had 
fewer embryos cells in G3 (5-7 positive stained-cells) after 48 hours of culture compared to OPS. 
However, we considered the efficiency of both procedures is equivalent for two reasons. First, 
embryos in grade 1 and 2 that represent >85% of total embryos after culture are the suitable 
quality to be used in embryo transfer. As the results showed (Table 5.1; 48 hrs) these embryos in 
both grades have no significant different between two vitrification procedures. Second, most 
embryos in terms of cellular damages were classified under 8 (Fig. 5.2) cells stained in PI, and it 
is known that morula by day 5 of a culture contain more than 100 cells. Therefore, the cellular 
integrity of vitrified embryos using different vitrification procedures induced minimum structural 
damages to the embryos, and produced the same survival rate.  
In summary, this study shows that a closed carrier is equivalent to an opened carrier to support 
the vitrification process for in vitro produced pig morula. Thus, we recommend using FS or other 
closed carrier in their vitrification protocol to store pig embryos in liquid nitrogen on a long-term 
basis. This recommendation would allow an improvement of the biosecurity of storage of 
germplasm against potential contamination coming from external sources.  
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CHAPTER 6   
6. GENERAL DISCUSSION, FUTURE DIRECTIONS AND CONCLUSIONS 
6.1 GENERAL DISCUSSION 
1- Is the general hypothesis of this study supported? 
Results of the different studies examined in this thesis supported the general hypothesis that 
delaying tmeiotic resumption of pig oocytes during in vitro maturation has a positive effect on 
oocyte competency for fertilization and embryo development. The studies in chapter 3 evaluated 
the ability of different follicular substances (NPPC, dbcAMP, NO, cGMP, estradiol, 
testosterone) to delay meiotic resumption  of pig oocytes. Three of substances, alone or in 
combination, were successful (NPPC+estradiol, dbcAMP, NPPC+estradiol+dbcAMP) in 
delaying meiotic resumption when adding to the maturation media (containing no LH) for the 
first 22 hrs of the maturation period. These substances were able to inhibit the meiotic 
resumption of most oocytes (>80%). The use of dbcAMP is a common way of inhibiting meiotic 
resumption in pig and bovine oocytes [14, 195, 365]; therefore, this group was selected as the 
control for the different study using a delay strategy. The inhibitory effect of NPPC+estradiol, 
dbcAMP, and NPPC+estradiol+dbcAMP appeared to be reversible as the oocytes resumed 
meiosis and completed nuclear maturation after being cultured for another 22 hrs in maturation 
media with LH. The combinations of NPPC+estradiol or NPPC+estradiol+dbcAMP were found 
to have the same ability to delay meiotic resumption  as dbcAMP to improve oocyte competence 
in pig [14] and bovine [365]. The benefit of delaying   a meiotic resumption  strategy is that it 
increases the time that oocytes maintain communication with cumulus cells [324]. This 
communication allows the oocytes and cumulus cells to exchange factors such that support 
oocyte cytoplasmic maturation [48]. Our results on embryo development indicated that delaying 
the meiotic resumption  strategy using different treatments (NPPC+estradiol, dbcAMP, 
NPPC+estradiol+dbcAMP) were equivalent to using Pff in the maturation media (Table 3.2, 
Chapter 3). The Pff has been found to provide a superior environment for oocyte maturation to 
improve its competence [190, 253, 446]. For this reason, it has been widely used with pig 
oocytes during IVM due to the beneficial effects on embryo development [255, 446]. Thus, this 
study used Pff as a control for the IVM procedure. Although Pff supports oocyte competence, it 
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is not acceptable commercially for IVM because it contains many unknown factors that may play 
a role in the maturation process [447]. This problem may make it difficult to evaluate the 
metabolic requirements of the oocytes. In addition, collecting Pff from different batches may 
lead to experimental variability because the Pff components can be variable due to the cyclicity 
status of the slaughtered pig [448], and age of the donors [441]. There is also a potential risk of 
Pff introducing contamination into the maturation media [9]. Therefore, using one of the 
inhibitory treatments (chemical-defined IVM media) to delay meiotic resumption can lead to 
consistent results by removing the variability induced by Pff. Consequently, delaying the meiotic 
resumption with a defined medium can help standardize IVM media in pig IVF as only BSA 
needs to be used in the media. This may lead to a commercial application of this technology 
benefitting the pig industry.  
 
2- Why do we need to find new substances to delay meiotic resumption when dbcAMP has 
shown successful results? 
The dbcAMP has been used to delay meiotic resumption in many species and has been shown to 
provide consistently positive results in embryo development [14, 195]. However, the wide range 
of biologic effects of cAMP [449] makes it hard to determine how this treatment could affect 
oocytes. It is possible that the positive effects of dbcAMP treatment resulted from its overall 
biological effects on the cell, not just its role in delaying meiotic resumption. To determine this 
point, different substances were evaluated to replace dbcAMP, including NO, cGMP, NPPC, 
progesterone, estradiol and testosterone (Chapter 3). Only NPPC+estradiol and the combination 
of NPPC+estradiol+dbcAMP demonstrated efficient results in delaying meiotic resumption 
(Chapter 3).  
When NPPC bind to its receptor (NPR2), an elevation in cGMP will stimulate an increase of 
cAMP concentration, as the dbcAMP will do. For this reason, the NPPC was found to delay 
meiotic resumption in pig oocytes. However, NPPC has not been studied regarding its effect on 
cytoplasmic maturation and embryo development in the pig. Therefore, the IVF-IVC was 
performed using NPPC+E and dbcAMP treatments to evaluate their effect on embryo 
development. The results of embryo development in our study did not show differences in 
embryo development between treatments (Chapter 3). Because cAMP could affect different 
pathways, the use of NPPC+E demonstrated that the main effect of dbcAMP in the oocyte is to 
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delay the meiotic resumption. This conclusion was supported by the fact that the combination of 
NPPC+E+dbcAMP did not show any difference in embryo development compared with other 
meiotic resumption delay treatments. So, the new combination of substances (NPPC+E and 
NPPC+E+dbcAMP) can be used to delay meiotic resumption to maintain meiotic arrest.  
 
3- Why NPPC alone did not have an inhibitory effect and why did it need the addition of 
estradiol to inhibit the meiotic resumption? 
The NPPC treatment prevented meiotic resumption by increasing cGMP production in cumulus 
cells, leading to an increase in the cAMP level in oocytes [362]. However, the results of study 1 
(Chapter 3) demonstrated that using 1000 nM of NPPC during the first 22 hrs of IVM did not 
prevent meiotic resumption. Thus, it could be hypothesized that the NPPC level used in our 
study was not sufficient to stimulate enough cGMP production to inhibit phosphodiesterase 3A 
and  degraded cAMP in oocytes [339]. The cGMP production in oocytes has been positively 
correlated with the NPPC levels in maturation media [355]. Therefore, it was expected that the 
inhibition of meiotic resumption require a higher level of NPPC to produce a sufficient amount 
of cGMP. The NPPC acts through NPR2 receptors in cumulus cells to stimulate cGMP. 
However, the NPR2 expression in cumulus cells decreased during the maturation period, even 
with the presence of NPPC in maturation media [339, 355]. The results showed (Fig. 3.4-A) that 
NPPC lost its inhibitory effect on meiotic resumption and it could be related to a reduction of 
NPR2 expression and insufficient production of cGMP in oocytes. .  
Many studies have found that estradiol can increase  NPR2 expression in the cumulus cells of 
mouse [100], pig [132, 355] and goat [339] oocytes. Therefore, it was assume that stimulating 
NPR2 expression by using estradiol in the presence of NPPC could produce a sufficient amount 
of cGMP to maintain meiotic arrest. The combination of NPPC plus estradiol in this study (Fig. 
3.4-D) efficiently prevented meiotic resumption over the first 22 hrs of IVM. Interestingly, a 
recent study in pig oocytes found that NPPC and estradiol in maturation media increased the 
cGMP level significantly compared to using estradiol or NPPC individually [100]. This finding 
supports the results of my thesis. In conclusion, NPPC requires estradiol to inhibit the meiotic 
resumption of pig oocytes.    
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4- Why is NO treatment not acceptable for delaying meiotic resumption?  
Nitric oxide (NO) plays an important role in meiotic arrest by stimulating cGMP production in 
cumulus cells [450]. Based on results of study 1 (Chapter 3), the minimum level of NO required 
to inhibit meiotic resumption was 1mM (Fig. 3.1). When NO was used in combination with 
NPPC, cAMP, E, and/or progesterone to delay meiotic resumption, the inhibition process was 
irreversible (see Appendix -8.2). Interestingly, removing NO from this combination allowed 
oocytes to resume meiosis after removing the inhibitory substances. The problem with using NO 
may result from the inhibition of the cumulus expansion. In our study, the degree of cumulus 
expansion was lower than with other treatments after NO treatment (Fig. 3.2), which suggests 
that the gap junctions are still present and the inhibition factors can be transferred from cumulus 
cells to oocytes. It has been reported that NO prevents the activation of LH-induced mitogen-
activated protein kinases (MAPKs) 1 and 2, that plays a role in breaking down the gap junction 
and stimulating cumulus expansion [117]. Although NO was able to inhibit meiotic resumption, 
this treatment was irreversible for meiotic resumption to put the oocytes into MII stage. In 
conclusion, NO is not recommended to use in delaying meiotic resumption in the concentrations 
that was used in our study.    
 
5- How does delaying meiotic resumption affect oocytes–cumulus cell communications?  
The main goal of delaying meiotic resumption is to maintain the communication of cumulus cells 
with oocytes for a longer period, in order to successfully improve the cytoplasmic maturation of 
oocytes. During this time, the oocytes can accumulate more molecules from cumulus cells, 
including proteins and RNA prior to meiotic resumption [324]. This accumulation in oocytes can 
support cytoplasmic maturation and improve oocyte competence [324]. Therefore, maintaining 
gap junction communication (GJC) between cumulus cells and oocytes is critical for enhancing 
the cytoplasmic maturation during meiotic arrest. The cumulus expansion reflects the nature of 
the communication between cumulus cells and oocytes [326]. The full cumulus expansion 
usually indicates a closure in the gap junctions has occurred, preventing the transport of 
molecules from cumulus cells to oocytes. It has been reported that GJC in cumulus-enclosed 
oocytes are maintained during meiotic arrest using NPPC and dbcAMP [132, 195, 235]. In our 
study, the degree of cumulus expansion was used to evaluate the nature of the communication 
between cumulus cells and oocytes. Our results showed a partial expansion of the cumulus under 
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different treatments (NPPC+estradiol, cAMP and its combination (CANE)) at the end of 22 hrs 
of IVM (Experiment 2.2). It could be hypothesized that the gap junctions between cumulus cells 
and oocytes during the meiotic arrest were still present. Finally, the partial cumulus expansion of 
COCs observed by the end of 22 hrs after delaying nuclear resumption (Chapter 3) indicated that 
the treatments should have maintained the communication between oocytes and cumulus cells. In 
conclusion, delaying meiotic resumption can maintain the GJC for a longer time based on our 
study; allowing oocytes to accumulate more molecules in cytoplasm that positively affect oocyte 
competence.   
 
6- Why do we need to evaluate the molecular changes in matured oocytes after delaying 
meiotic resumption? 
The changes in gene expressions can highlight many of the requirements that oocytes need to be 
competent. The delaying of the meiotic resumption strategy was reported to improve oocyte 
competence [14, 324, 451]. This strategy has been performed with many substances (cAMP, 
NPPC+E, cAMP+NPPC+ E) which expected to have different effects on the molecular condition 
of oocytes. However, no study has evaluated the molecular changes in matured oocytes after 
using this protocol (the two-step strategy). Evaluating the molecular pathways and the gene 
expression patterns can identify different biological responses that happen under certain 
conditions. In our study, identifying the molecular pathway and gene expression changes allows 
us to increase our understanding of the effects of the treatments used in oocytes during the 
maturation period. Understanding the behavior of these treatments at a molecular level explained 
the differences in our results. 
 
7- Why do using different delaying nuclear maturation treatments cause different 
molecular and gene expression responses?   
The environment of oocytes during IVM can critically affect oocyte competence, depending on 
the substances used in the IVM media [452, 453]. The maturation environment can have a major 
impact on gene expression in oocytes [454], which may correlate with oocyte competence [388]. 
The results of our gene expression study of matured oocytes (Chapter 4) indicated that using 
different substances in the first 22 hrs of IVM affected gene expression and pathways differently. 
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One possible reason for these differences in molecular responses between treatments is the 
various effects of substances used in the study on intracellular signal [455]. In CA treatment, the 
elevation of cAMP up-regulated the transcription of many genes related to the signal 
transduction (ARHGAOP90, RGS5, BRAF, STAT2, and STAT2) between cytoplasm and 
nucleus [455]. Some of these signal transduction factors play an important role in oocyte 
competence. The JAK/STAT signal pathway is an example of an up-regulating pathway for a 
transducer signal involved in cell proliferation and development that supports oocyte competence 
[456, 457]. In addition, increasing the level of cAMP activated protein kinase A that up-regulates 
genes involved in the signal from cell membrane to the nucleus (such as BRAF gene that 
encoding B-Ref protein) [458] and involves signals that are important for oocyte competence. 
The B-Ref plays an essential role in regulating the MAP kinase/ERKs signaling pathway that 
affects cell division, differentiation and development of a cell. The ERK pathway demonstrates a 
direct link between growth factor signaling to ribosome biosynthesis, via the ERK-dependent 
phosphorylation of BRAF [45]. These results indicated that CA treatment can support oocytes 
development by activation MAPK pathways and genes participating in oocyte competence (such 
as MRPL3 and HSP90AA1) [389, 395].   
Although the NPPC+estradiol (NE) treatment has been shown to increase the level of cAMP in 
oocytes [100] similar to dbcAMP treatment, the gene expression and pathways did not show the 
same molecular response. This result may reflect the effect of different substances in each 
treatment (NPPC and estradiol with NE; cAMP with CA treatment) on molecular pathway 
changes. In this treatment, an elevation in the cGMP level in cumulus cells is expected and 
should transfer to oocytes [459]. The PPARG signaling pathway, which plays an important role 
in the metabolic process and female fertility, was found to be up-regulated under the effect of 
PKG (stimulated by cGMP) [460]. Many of up-regulated genes in NE treatments are involved in 
MAPK pathways such as: MAPK9, MAX, and REL that support oocytes development and 
growth [390, 398]. Also, the NE treatment activated the oxidative stress response pathway that 
reduce the reactive oxygen species damage in oocytes during IVM [402]. Therefore, these 
different responses of oocyte to NE treatments can support oocyte development and growth 
leading to embryo development.  
It was expected that the CANE treatment would have many common genes differentially 
expressed compared to other treatments. However, the number of the genes in common between 
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CANE with CA and NE treatments was limited to single gene (Fig. 4.1). It is important to 
consider that we used a two-fold cut-off value in change gene expression in treated oocytes 
compared to the control (Pff), and this limited us to a specific number of genes. However, when 
we considered genes with an expression less than a two-fold change from the control, we 
observed more genes in common among the treatments (data not shown). The other possibility 
for the low number of common genes among treatments is the interaction between cAMP and 
estradiol functions could change profile of gene expression in oocytes during in vitro maturation. 
Studies have demonstrated this interaction, specifically, the effect of cAMP on modulated 
functions of the estrogen receptor [383]. Estradiol has been documented to increase the cAMP 
production in sufficient level to stimulate response to mediated gene transcription [461]. In an 
example of this interaction, a study demonstrated that the gene expression of IHCGR and 
ESR2A following a stimulation by cAMP and estradiol was significantly different compared to 
the use of estradiol or cAMP alone [387]. Therefore, it is possible that the interaction of estradiol 
and cAMP in CANE treatment on gene expression could induce the expression of different genes 
compared to CA or NE  
Overall, although the treatments to delay meiotic resumption were at the same level, our results 
indicated that the effects of each treatment at the molecular pathway and gene expression level 
were different due to the different substances. However, these differences in molecular responses 
to various treatments did not affect embryo development among the treatments (Chapter 3).      
 
8- Can we use a biosecure method to vitrify pig embryos?    
The embryos derived from oocytes in pigs are extremely cryosensitive due to cytoplasmic in 
vitro maturation conditions and the high lipid content [462, 463]. Pig embryos were successfully 
vitrified using opened carrier devices, such as open pulled straw and cryoloop [423, 464]. This 
success was due to a rapid cooling rate, resulting from direct contact with liquid nitrogen [313]. 
However, the direct contact of LN2 can increase the possibility of embryo contaminations by 
microbial pathogens and viral agents [430]. In our final study (Chapter 5), we evaluated the 
ability to vitrify embryos (morula) using a closed carrier (FS) compared to an opened carrier 
(OPS) in order to increase the biosecurity of the storage procedure. The results of this study 
showed that 62% of embryos vitrified with the closed carrier straw had a quality grade 1 after 
warming and culture for 48 hrs. These results indicated that the vitrification of the embryo using 
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both methods maintained a high rate of grade 1embryo quality. However, FS method prevented 
degradation of embryo quality compare to the usage of OPS after warming and 48 hrs of culture. 
Furthermore, the results of cell integrity (Fig. 5.1, Chapter 5) showed that almost 80% of morula 
had few cells stained with PI (< 4 cells), indicating good cell integrity in embryos preserved with 
both vitrification procedures. These different results indicated that a low cooling rate associated 
with closed carrier devices may not be critical to the quality of embryos vitrified using this 
method.  
However, the vitrified embryos did not develop to further stages after warming and culturing 
them for 48 hrs. Suboptimal culture conditions could be a major factor affecting the yield and 
quality of pig embryos produced in vitro. The difficulty in standardizing the conditions of the 
culture is one of the reasons associated with variable results in embryo development using 
different culture media [443]. The difficulty to meet specifically all the requirements for embryo 
development during in vitro culture can be an important obstacle [191]. 
Assessing the integrity of cells using PI staining for embryos cannot confirm the viability of the 
embryo. The cryopreservation procedures can damage cells of the embryo during the vitrification 
or warming process. The number of dead cells in the embryo is important in determining embryo 
development and quality [465]. It was demonstrated that when the proportion of dead cells in a 
vitrified-warmed bovine embryos did not exceed 10%; and an embryo in this range of dead cells 
was considered to be fit for survival and development [466]. Also, it was found that an 
increasing the number of dead cells (stain with PI) in mouse embryos reduced the quality of 
embryos but did not kill the embryos [467]. In our study, PI permeability in both methods 
showed that >90% (Chapter 5, Fig. 5.2) of embryo had ≤ 4 cells stained with PI after 
vitrification, warming and culturing for 48 hrs. We can hypothesize that these embryos were in 
the range to fit for survival and development. However, our pig embryo did not develop into a 
blastocyst stage, which could be due to the culture conditions (as previously discussed). 
The importance of having a biosecure method relates to the ability to store embryos in a way to 
prevent possible contamination. This topic is important because pig industry faces big challenges 
due to potential outbreak of diseases such as Porcine Epidemic Diarrhea (PED) and Porcine 
Reproductive and Respiratory Syndrome (PRRS) [468]. Live replacement animals may carry 
diseases and contaminate a seed-stock (nucleus) of a farm if the biosecurity measures are not 
respected adequately. The semen is another possible source for disease outbreak through 
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movement of semen between farms. Artificial insemination using contaminated semen in 
multiple sows could severely increases the risk of disease outbreaks. Therefore, semen testing is 
a critical procedure before shipping to prevent disease distribution [469]. If a pathogen is not 
detected in the semen, it could spread rapidly in multiple nucleus farms. 
Thus, it is important to find a ways to reduce the possibility of direct transmission by live 
animals moving between different farms in order to control disease outbreaks. Using vitrified 
embryos under biosecured conditions, could help to reduce the possibility of contamination 
because these embryos can be tested before being introduced into a recipient. In addition, this 
method can be applied in many areas requiring protection of embryos over a long term, such as 
preserving embryos in a cryobank or transferring embryos nationally or internationally.  
 
9-How different techniques that we investigated in our study can be applied in commercial 
work?   
Many reproductive techniques have been applied in domestic animals at the commercial level to 
improve the productivity and product quality, such using embryo transfer, IVP, artificial 
insemination, and cryopreservation. IVP is one of the techniques that are used with embryo 
transfer to introduce new genetic material to improve the performance of herd productivity. In 
the pig, the IVP performance is still not efficient to produce viable embryos. Our study used a 
strategy to delay meiotic resumption during the first 22 hours of IVM to improve the competence 
of the pig oocyte to sustain embryo development after fertilization. Our results did not 
demonstrate an advantage to delay meiotic resumption for the in vitro production of pig 
embryos. However, we demonstrated that these embryos can be produced to an equivalent rate in 
a defined medium; leading to a potential commercialization of the IVP of pig embryos. Also, the 
vitrification of pig embryos is an important technique that can be used in different applications, 
such as embryo transfer or long-term conservation. Although the opened carrier has been 
successfully used in pig embryo verification, this method is not acceptable for the transport of 
vitrified embryo internationally. The International Embryo Technology Society (IETS) 
recommends, in term of biosecurity, using the closed carrier to transfer vitrified embryo abroad. 
In our study, we found FS (closed carrier) can provide equivalent results in pig embryo 
vitrification to OPS (opened carrier). Thus, FS can be used commercially in vitrification of the 
pig embryo and to transport embryos between countries with lower costs than using live animals. 
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6.3 FUTURE DIRECTIONS 
The results of the different studies conducted in this thesis highlight some future directions for 
research that can help to improve IVP in pigs, thereby increasing our understanding of oocyte 
competence. The following points are suggestions for future studies that could be performed: 
1- Based on results from chapter 3, delaying meiotic resumption had an embryo development 
equivalent to using the standard procedures (Pff). However, enhancing the results of our 
treatments may require more than just delaying meiotic resumption. Improving the maturation 
conditions during meiotic arrest by using additives may help to enhance oocyte competence. 
Many studies have indicated the possibility of improving the developmental competence of 
oocytes by using appropriate additives in the maturation media during IVM, such as: ascorbic 
acid [47], GDF9 and BMP15 [48, 49]. Therefore, it is possible to use of additives during the 
inhibition of the meiotic resumption period to influence embryo development positively.  
 
2- Another possible suggestion for improving oocyte competence is to increase the period to 
delay meiotic resumption. The results of our study showed that using 22 hrs to delay meiotic 
resumption by using different treatments had the same effect on embryo development as Pff 
treatment. Therefore, increasing the communication time between cumulus cell and oocytes may 
result in the accumulation of more molecules that could have additional positive effects on 
cytoplasmic maturation and, consequently, oocyte competence. We can hypothesize that 
increasing the time of meiotic inhibition greater than 22 hrs; (mean 22-32 hrs of IVM) could 
have beneficial results. The reason I would selected this period is that under personal observation 
in our lab, we found that incubating the nuclear-delayed oocytes for 8-10 hours with maturation 
media with LH can oocytes reach MII (around 60%). 
3- During study 1 (Chapter3), it was observed that NPPC with 1000 nM could not prevent 
meiotic resumption without adding estradiol (100 ng/ml) to maturation media. However, there is 
question: If we add estradiol to lower concentrations (100, 250, 500 nM) of NPPC that were used 
in this study, can they effectively prevent meiotic resumption? A dose-response was not done in 
this study, due to previous results obtained in our lab demonstrating the optimal concentration to 
be used in our strategy. This new interaction between estradiol and NPPC demands to investigate 
again the dose response effect of estradiol in combination with estradiol.  
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4- Further research needs to evaluate the effect of delaying meiotic resumption on gene 
expression related to oocyte competence in cumulus cells. The cumulus cells play an important 
role in oocyte competence [5, 50]. Many gene markers (hyaluronan synthase 2 (HAS2), inhibin 
bA (INHBA), epidermal growth factor receptor (EGFR), gremlin 1 (GREM1), betacellulin 
(BTC), CD44, tumor necrosis factor-induced protein 6 (TNFAIP6), and prostaglandin-
endoperoxide synthase 2 (PTGS2)) were identified in cumulus cells related to oocyte 
competence and cumulus cell functioning in both human and bovine subjects [52, 53]. The effect 
of each inhibitory treatment on gene expression of cumulus cells could help to determine their 
roles on oocyte competence and cumulus cell functions.   
 
5- Further research is needed to evaluate the effect of using embryos derived from the delaying 
meiotic resumption strategy (two-step strategy) in the vitrification procedures. Pig embryos are 
sensitive to cryopreservation procedures [463], which could suggest an insufficient cytoplasmic 
maturation of oocytes [38]. Delaying meiotic resumption  is expected to improve cytoplasmic 
maturation [324]. Therefore, it is expected that the embryo derived from delaying meiotic 
resumption will be more competent and can be vitrified successfully.  
6- The results of vitrified embryo after warming (Chapter 5) did not develop a further stage. The 
possible reasons for this problem were discussed earlier in chapter 5. The key to understanding 
this problem is to identify the viability of vitrified embryo. Staining some cells with PI in 
embryo can indicate a damaged embryo, but not a dead embryo. Transferring the vitrified 
embryos to sows may help to confirm the viability of an embryo and its ability to reach further 
stages of development.   
 
6.4 WHAT IS THE OVERALL CONCLUSION OF THE THESIS? 
1- Delaying meiotic resumption in pig oocytes during IVM can have a positive effect on the 
results of embryo development comparable to using Pff treatment.  
2- Meiotic resumption in pig oocytes can be delayed successfully using the following treatments: 
NPPC (1000 nM) + estradiol (100 ng/ml), dbcAMP (1 mM) or the combination of both 
treatments for 22 hrs.  
 95 
 
3- Different media that were used in delaying meiotic resumption strategy represent can be 
alternatives to using Pff during IVM. A standardization of the maturation media for IVM in pigs 
is required in order to make IVP more appropriate for use in commercial applications.  
4- Our microarray study indicated that each inhibitory treatment has its own molecular effects 
that enhance the level of oocyte competence resulting in embryo development. 
5- French straw carrier (a closed system) was found to be equivalent to using the OPS method 
(opened system) to vitrify pig embryos. From biosecurity point view, using the French straws 
can be the recommended method used to vitrify pig embryo, as they offer full protection from 
contamination during storage in liquid nitrogen.   
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CHAPTER 8 
APPENDIX 
Introduction  
This research conducted numerous trials to develop a strategy to improve IVP in pig. During our 
study, there were many challenges to achieving acceptable IVP results. The obstacles were 
typical as there are many issues that continue to need to be overcome in pig IVP. This appendix 
describes the different trials that were run and procedures developed during the research. 
 
8.1  In vitro embryo production obstacles 
In vitro embryo production during this study has many obstacles that for a time delayed our 
progress. Between August and October 2012, the cleavage rate and blastocyst rates ranged 
between 50-70% and 0-20%, respectively. However, the cleavage pattern and blastocyst rate 
declined over time, especially by mid-October and several months later (Fig. 8.1). Various 
modifications were applied to resolve this problem. In general, the cleavage rate during October 
2012 to May 2013 ranged between 0-25% and there was no blastocyst production (Fig. 8.1). 
Over this time, many trials were run to investigate this problem and to check on the following 
considerations: 
A- Microbial or viral contamination: Most the equipment in the lab was sterilized and 
samples were checked for viral contamination (negative results) in the microbiology lab. 
Therefore, it was assumed that microbial or viral contaminations were not the reason for 
this problem.  
B- Nuclear maturation rate of oocytes: The rate for oocytes that reach MII is critical to 
achieving normal embryo development. Most the results of nuclear maturation (MII) had 
a rate of around 70%.   
C- Ammonium concentration: In March 2012, our group was made aware of a high level 
of ammonium in the college. The embryos are very sensitive to ammonium and this may 
have been the reason for the low cleavage rate. To deal with this problem, a benchtop 
incubator was put into use to produce a positive air environment. As such, ambient air 
cannot reach the fertilized eggs. The cleavage rate increased (30%) and morulas were 
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produced. However, there were no blastocysts produced. To test the possibility that 
ammonium was the main factor affecting the production of a blastocyst, an air purifier 
was purchased to capture the ammonium. There was some improvement regarding the 
viability of oocytes and production of a few blastocysts. However, this did not reach the 
level obtained in August and September 2012. 
D- Evaluation of semen concentrations during IVF: During the evaluation period for the 
IVP protocol, the concentration of semen added to oocytes during IVF was assessed. The 
oocytes were matured using Pff (10%). By the end of IVM, different semen 
concentrations (10000, 5000, 1000, 500, 250, 100 and 50 sperm/oocyte) were tested 
during IVF. The results for cleavage rate were variable between 0-30%, and no 
blastocysts were produced.  
E- Using oocytes of sows for IVF: Sow oocytes are usually more competent than oocytes 
from pre-pubertal gilt. Therefore, sow oocytes were used for IVP with the expectation of 
better results associated with oocytes that are more competent. However, the cleavage 
rate continued to only range between 8-10% with no blastocyst production.  
F- Evaluation of different culture media: Different culture media were evaluated to 
identify the effect of culture media on the results of IVP. NCSU-23 [150] that was 
prepared commercially or in the lab and E-BLAST (Minitube, Canada) were used during 
IVC. However, there was no improvement in cleavage rate (0-20%) and most of the cells 
were degraded. Recently, our lab followed a new strategy during IVC using NCSU-23. 
The energy recourses during the first two days of IVC used sodium pyruvate and sodium 
lactate which replaces glucose for the remaining seven days of the culture period. We 
found  using this strategy helped to improve the cleavage and blastocyst rate. 
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Fig. 8.1: The cleavage rate that were obtained over one year using the old lab and new 
laboratories. 
 
8.2 Effect of a mix of inhibitors on final nuclear maturation 
The aim of this experiment was to determine the effect of exposure of oocytes to a mixture of 
substances that inhibit meiotic resumption for different periods during IVM on nuclear 
maturation and embryo development. COCs were aspirated and selected to transfer into a 
maturation medium supplemented with nitric oxide (1 mM), NPPC (1000 nM), cAMP (1 mM) 
estradiol and progesterone (100 ng/ml). The mix of substances was added to maturation media 
(without LH) from the beginning of IVM for different lengths of time (2, 6, 18, 22 hr). Then, the 
COCs were transferred to regular maturation media (with LH) to complete the IVM period (44 
hr).  By the end of IVM, the COCs were denuded and the oocytes fixed in 4% formaldehyde for 
staining  using a LAMIN/DAPI stain to assess the nuclear maturation stages (Fig. 3.1-A). The 
results showed that when oocyte exposure to this mixture was from 6 to 24 hrs of IVM, more 
than 50% of oocytes did not initiate meiotic resumption  after removing the mixed media. The 
rate of oocytes in the GV stage increased significantly with an increase in time of delaying 
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meiotic resumption. However, removing NO from the mix was found to improve the rate of 
oocytes that reached MII after nuclear delay resumption (Fig 8.2-B). The results of this work 
indicated that NO with a dose of 1 mM was irreversible for meiotic resumption  on oocytes. This 
effect increased with longer NO incubation with oocytes during IVM.   
 
 
 
Fig. 8.2:  Effect of a mixture of substances on nuclear maturation rate by the end of IVM. A) The nuclear 
maturation rate for oocytes treated with a mixture including cAMP (1mM), NO (1mM), NPPC (1000 nM) 
plus estradiol and progesterone (100 ng/ml). B) The nuclear maturation rate for oocytes treated with same 
mixture without NO. 
 
8.3 Oocytes and embryo viability test  
The cell viability assay used in this research is a  procedure to determine whether cells are living 
or dead based on staining with propidium iodide (PI) that binds to DNA by intercalating between 
the bases with little or no sequence preference. During experiment 1 (Chapter 3) and experiment 
3 (Chapter 5), the viability of the oocytes and embryos were studied for a complete assessment 
of the effect of treatments. The following procedure was adapted from a protocol compiled from 
LIVE/DEAD® Sperm Viability Kit assays (L-7011).  
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Procedure: 
A. Prepare washing buffer (0.1% PVA) by dissolving 0.05 g of PVA in 50 ml PBS 1X. 
B. Wash the denuded oocytes or embryo 3X with washing buffer.  
C. Add 5 ul from the propidium (PI) solution (Invitrogen, 1 mg/ml) to the 1 ml washing buffer 
and mix them by pipetting.  
D. Transfer the oocytes or embryos to a propidium iodide solution (from C) with a minimum 
aliquot from a washing buffer washing buffer (A). 
E. Incubate the sample for 7 minutes at 38.5ºC. 
F. Wash the oocytes with washing buffer 3X. 
G. Pick out the oocytes and mount them with minimal media on slides, add cover slips (with 
Vaseline/paraffin on four corners) and gently press down on the cover slip or put them in a 
droplet of washing buffer. 
H. Observe oocytes under an epifluorescence microscope. 
I. All oocytes that have a red stain in the nucleus are considered dead, while others that are not 
stained are considered alive. 
 
 
Fig. 8.3: A) Oocytes  were stained using PI to identify dead cells B) Morula  were stained with PI and the 
fluorescent spots show the number of cells that have memberanes that allow PI to penetrate.   
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8.4 Effect of delaying meiotic resumption  using NPPC+ estradiol during IVM on 
embryo development of Meishan sows  
This experiment evaluated the effect of using NPPC+E as a delay resumption of nuclear strategy 
during IVM on oocytes from Meishan sows to improve IVP performance. The COCs were 
transported from the USA in a maturation media with NPPC+E treatment. When the COCs were 
received after a 22-24 hr of shipping time, they were washed in maturation medium containing 
LH, but without inhibitory substances. They were then incubated for another 22 hrs. 
By the end of IVM, the process was continued with IVF and IVC as described in chapter 3. The 
results of embryo development are described in Table 8.1. In general, the blastocyst rate was 
around 10%. This work still needs further evaluation because the result came from only one 
replicate and the effect of transport on COCs from different sources may affect embryo 
development results.    
 
Table 8.1: The results of embryo development derived from oocytes of Meishan sows. These oocytes 
were treated with NPPC+E to delay meiotic resumption and transported from the USA to our laboratory. 
After first 22 hrs of IVM with treatment, oocytes were transferred to maturation media without inhibition 
substances to complete the rest of IVM period.  
